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FUNCTIONAL CHARACTERIZATION OF THE ARGININE TRANSAMINASE
PATHWAY IN PSEUDOMONAS AERUGINOSA PAO1
by
ZHE YANG
Under the Direction of Chung-Dar Lu

ABSTRACT
Arginine utilization in Pseudomonas aeruginosa with multiple catabolic pathways
represents one of the best examples of metabolic versatility of this organism. To identify
genes of this complex arginine network, we employed DNA microarray to analyze the
transcriptional profiles of this organism in response to L-arginine. While most genes in
arginine uptake, regulation and metabolism have been identified as members of the ArgR
regulon in our previous study, eighteen putative transcriptional units of 38 genes
including the two known genes of the arginine dehydrogenase (ADH) pathway, kauB and
gbuA, were found inducible by exogenous L-arginine but independent of ArgR.
The potential physiological functions of those candidate genes in L-arginine
utilization were studied by growth phenotype analysis in knockout mutants. The insertion
mutation of aruH encoding an L-arginine:pyruvate transaminase abolished the capability
to grow on L-arginine of an aruF mutant devoid of a functional arginine
succinyltransferase (AST) pathway, the major route of arginine utilization. The aruH
gene was cloned and over-expressed in E. coli. Taking L-arginine and pyruvate as the
substrates, the reaction products of recombinant enzyme were identified by MS and

HPLC as 2-ketoarginine and L-alanine. Lineweaver-Burk plots of the data revealed a
series of parallel lines characteristic of ping-pong kinetics mechanism, and the apparent
Km and catalytic efficiency (Kcat/Km) were 1.6 ± 0.1 mM and 24.1 mM-1 s-1 for pyruvate
and 13.9 ± 0.8 mM and 2.8 mM-1 s-1 for L-arginine. Recombinant AruH showed an
optimal pH at 9.0 and substrate specificity with an order of preference being Arg > Lys >
Met > Leu > Orn > Gln. These data led us to propose the arginine transaminase (ATA)
pathway that removes the α-amino group of L-arginine via transamination instead of
oxidative deamination by dehydrogenase or oxidase as originally proposed. In the same
genetic locus, we also identified a two-component system, AruRS, for the regulation of
arginine-responsive induction of the ATA pathway.
Our latest DNA microarray experiments under D-arginine conditions also revealed
PA3863 as the candidate gene encoding D-arginine dehydrogenase which might lead to
the recognition of a wider network of arginine metabolism than we previously
recognized.

INDEX WORDS: arginine catabolism, Pseudomonas aeruginosa, ATA pathway, twocomponent system, ArgR, DNA microarray, transaminase, kinetics.
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General Introduction
Biosynthesis and metabolism of arginine in microorganisms have been carefully
reviewed in many aspects (Abdelal, 1979; Cunin et al., 1986; Haas, 1990; Itoh, 2004; Lu,
2006). In this introduction, only the information related to this dissertation is briefly
summarized and discussed.

0.1 ARGININE CATABOLISM BY MICROORGANISMS.
Arginine can serve a broad range of microorganisms as a growth substrate, a building
block of proteins and a precursor of polyamine synthesis. All the major arginine catabolic
pathways are initiated by one of the following five chemical reactions (Fig. 0.1): 1) the
hydrolytic cleavage of arginine by arginase forms ornithine and urea; 2) arginine
deamination produces citrulline and ammonia; 3) the decarboxylation of arginine
generates agmatine, which is then converted into putrescine; 4) the transamination or
oxidation of the α-nitrogen atom of arginine results in the generation of 2-ketoarginine;
and 5) the succinyl-coenzyme A dependent succinylation of arginine initiates the
conversion of arginine to glutamate and succinate (Cunin et al., 1986). Remarkably,
multiple arginine catabolic pathways were frequently found in the same organism,
especially among the members of pseudomonas species (Cunin et al., 1986; Haas, 1990;
Itoh, 2004). The possession of different arginine catabolic pathways in these bacteria may
have particular survival significance to them in fluctuating environments. Therefore, the
study of arginine catabolism by microorganism will provide exciting findings in the fields
of enzymology, genetic regulation mechanisms and metabolic physiology.
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0.2 P. AERUGINOSA IS A GOOD MODEL MICROORGANISM TO STUDY
ARGININE CATABOLISM.
P. aeruginosa is a Gram-negative bacterium that causes life-threatening infections in
immunocompromised persons and chronic infections in cystic fibrosis patients (Rahme et
al., 1995). The potential pathogenicity of this opportunistic human pathogen is greatly
enhanced by its extraordinary nutritional versatility, which gives it an exceptional ability
to colonize ecological niches where nutrients are limited (Stover et al., 2000).
Arginine catabolism is of particular significance in P. aeruginosa, which can utilize
arginine efficiently as the sole source of carbon, nitrogen and energy through four
different

pathways:

the

arginine

deiminase

(ADI)

pathway,

the

arginine

succinyltransferase (AST) pathway, the arginine decarboxylase (ADC) pathway and the
arginine dehydrogenase (ADH, also called arginine oxidase) pathway (Haas, 1990; Itoh,
2004; Lu, 2006). The decarboxylation of arginine generates agmatine, which can be
further converted into putrescine and spermidine. The presence of multiple arginine
catabolic pathways and the link of arginine to polyamine biosynthesis constitute a
complicated metabolic network of arginine and polyamines in this organism (Haas, 1990;
Itoh, 2004; Lu, 2006). Therefore, P. aeruginosa serves as an excellent model organism
for studying arginine catabolism.
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0.3 ARGR AND ARGININE CATABOLISM IN P. AERUGINOSA
There are four pathways for L-arginine catabolism in P. aeruginosa. Under anaerobic
conditions, L-arginine can be used by P. aeruginosa mainly through the ADI pathway to
provide ATP to support its motility and slow growth (Vander Wauven et al., 1984). Anr,
the anaerobic regulatory protein (Gamper et al., 1991), is essential for the induction of the
arcDABC operon, which encodes an arginine: ornithine antiporter and the enzymes of the
ADI pathway. Exogenous L-arginine can further induce the expression of this operon
through the interaction of Anr with the arginine-responsive regulatory protein, ArgR
(Park et al., 1997a; Park et al., 1997b). On the other hand, under aerobic conditions, Larginine can be used by P. aeruginosa through the AST, ADC and ADH pathways. The
AST pathway is the major route of L-arginine utilization by P. aeruginosa (Itoh, 1997).
An aru-null mutation almost abolishes the L-arginine utilization by this strain (Itoh,
2004). The AST pathway converts L-arginine to glutamate and succinate by five
enzymatic steps (Fig. 1.1). Both the aru operon encoding the enzymes of the AST
pathway and the gdhB gene encoding a catabolic glutamate dehydrogenase are induced
by ArgR in the presence of exogenous L-arginine (Lu and Abdelal, 1999; Lu and
Abdelal, 2001; Park et al., 1997a). The ADC pathway converts L-arginine into putrescine
via agmatine and N-carbamoyl putrescine and it is assumed that this pathway supplies
polyamines when arginine is abundant (Haas, 1990; Mercenier et al., 1980). The speA
and adcA genes of the ADC pathways are again regulated by ArgR. In P. aeruginosa,
ArgR is autoinduced by exogenous L-arginine from aotjQMOP-argR operon and its
DNA-binding activity appears to be independent of L-arginine (Nishijyo et al., 1998;
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Park et al., 1997a; Park et al., 1997b). Thus for all the above three pathways (the ADI,
AST and ADC pathways) of L-arginine catabolism, ArgR is the positive regulator.

0.4 PROPOSAL OF THE ADH PATHWAY.
The above mentioned three pathways are well characterized in P. aeruginosa.
However, very little is known about the fourth L-arginine catabolic pathway, the ADH
pathway. The ADH pathway was first discovered in Streptomyces griseus (Cunin et al.,
1986), then in P. putida (Vanderbilt et al., 1975) and P. aeruginosa (Voellym and
Leisinger, 1976). Using the ADH pathway, S. griseus degrades L-arginine via 4guanidinobutyramide, 4-guanidinobutyrate (4-GB), 4-aminobutyrate and succinate
semialdehyde. The ADH pathway in P. aeruginosa (Haas, 1990) and P. putida are
similar but not identical to that in S. griseus. As shown in figure 1.1, L-arginine is first
oxidized into 2-ketoarginine by L-arginine oxidase. Then 2-ketoarginine is converted to
4-guanidinobutyraldehyde

(GUBAL)

by

2-ketoarginine

decarboxylase.

4-

guanidinobutyraldehyde dehydrogenase successively catalyzes the formation of 4-GB.
Subsequent intermediates are 4-aminobutyrate and succinate semialdehyde which is
finally channeled into the tricarboxylic acid (TCA) cycle. The ADH pathway in P. putida
was proposed based on detection of the intermediates of L-arginine catabolism and
further demonstration of the predicted enzymes involved in those steps. To detect those
14

intermediates of the ADH pathway, L-[U- C] arginine were incubated with intact cells
and with cell extracts. The reaction mixtures were then fractionated by paper
chromatography and high voltage electrophoresis (Miller, 1972; Vanderbilt et al., 1975).
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The enzymes of the ADH pathway were demonstrated by enzyme assays from cell crude
extract (Chou and Rodwell, 1972; Jann et al., 1988; Miller, 1972; Vanderbilt et al., 1975).
P. aeruginosa can utilize all the compounds below 2-ketoarginine as good carbon and
nitrogen sources (Stalon and Mercenier, 1984). By analogy, it was expected that the same
pathway existed in P. aeruginosa (Haas, 1990).
Though P. aeruginosa possesses the same set of the enzymes downstream of 2ketoarginine decarboxylase as P. putida (Fig. 1.1), all the attempts to demonstrate the
presence of L-arginine oxidase in P. aeruginosa were unsuccessful (Jann et al., 1988).
The activity of L-arginine: 2-oxoglutatate transaminase, another enzyme catalyzing the
conversion of L-arginine to 2-ketoarginine, could not be detected in this microorganism
either. The discovery of a D-arginine inducible D-arginine dehydrogenase (Jann et al.,
1988) provided the possible route for D-arginine utilization in P. aeruginosa eventually.
Since current research regarding the ADH pathway mainly focuses on the nature of
the enzymatic steps involved, little is known about the genes encoding the enzymes of the
ADH pathway. Only gbuA gene encoding guanidinobutyrase of the ADH pathway has
been

characterized

(Nakada

and

Itoh,

2002).

kauB

gene

encoding

4-

guanidinobutyraldehyde dehydrogenase (Jann et al., 1988), gabD gene encoding
succinate-semialdehyde

dehydrogenase

and

gabT

gene

encoding

4-

aminobutyrateaminotransferase have just been mapped in P. aeruginosa but not yet
cloned. The genes, which encode arginine oxidase/dehydrogenase/transaminase and 2ketoarginine decarboxylase for the first two steps of the ADH pathway, are still
unknown. In order to fully understand the regulatory mechanism of arginine network in
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P. aeruginosa, it is crucial to identify and characterize the unknown genes of the ADH
pathway.

0.5 DNA MICROARRAY AND CELL METABOLISM.
Identification of genes responsible for certain catabolic pathway usually includes the
following steps: 1) demonstration of proposed enzymatic activity; 2) purification of the
protein responsible for this enzymatic activity; 3) determination of peptide sequence for
this protein; 4) conversion of protein sequence into DNA sequence; and 5) gene cloning
and over-expression. Or, genome-wide transposon mutagenesis may also be a choice
when combined with the screening of phenotypic mutants. Those traditional approaches
are time-consuming, and sometimes may not be feasible.
Recent technological advances have made it possible to study global gene expression
in both prokaryotic and eukaryotic organisms by using high density oligonucleotide
microarray. The complete sequence of the genome of P. aeruginosa strain PAO1 has
been published in 2000 (Stover et al., 2000), and the extraordinary nutritional versatility
of this organism is reflected by its relatively large genome (6.3Mbp) and genetic
complexity (5,570 open reading frames). Not surprisingly, the genome of P. aeruginosa
possesses more than 9% of the assigned open reading frames which are classified as
transcriptional regulators and two-component systems, reflecting the capability of the
organism to adapt to changing environmental conditions (Stover et al., 2000).
Considering little known genetic information of the ADH pathway and the relatively
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large size of the P. aeruginosa genome, we chose the DNA microarray technology to
identify the unknown genes of the ADH pathway in an efficient and systematic way.
The P. aeruginosa Genome Array was developed by Affymetrix and the Cystic
Fibrosis Foundation. The array represents the annotated genome of P. aeruginosa strain
PA01 and includes 5,549 protein-coding sequences, 18 tRNA genes, a representative of
the ribosomal RNA cluster and 117 genes present in strains other than PAO1. In addition,
199 probe sets corresponding to all intergenic regions exceeding 600 base pairs have
been included. The selected probes have been screened against sequence homologies in
the existing database of human genes. This GeneChip probe array is a powerful tool for
monitoring transcriptional regulation and antimicrobial agent response of P. aeruginosa.
In our DNA microarray experiments, the total RNA samples were prepared from P.
aeruginosa wild type strain PAO1 and its argR mutant strain PAO501 grown in
glutamate minimal medium P (MMP) in the presence and absence of L-arginine under
aerobic conditions. Since the ArgR protein has proven to be an important regulator for
arginine utilization in P. aeruginosa, we made the hypothesis for the expression patterns
for those arginine metabolic genes (Fig. 0.2). For those arginine biosynthetic genes, they
may show basal levels of expression in the wild type strain PAO1 and its argR mutant
strain PAO501 grown in the absence of L-arginine. When the bacteria cells are grown in
the presence of L-arginine, those arginine biosynthetic genes may be repressed and this
arginine repression effect may be abolished when the regulatory protein, ArgR, is
inactivated. Similarly, those arginine catabolic genes may show basal levels of expression
in the wild type strain PAO1 and its argR mutant strain PAO501 grown in the absence of
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L-arginine. However, those arginine catabolic genes may be induced when the bacteria
cells are grown in the presence of L-arginine and this arginine induction effect may be
abolished when the regulatory protein, ArgR, is inactivated as shown in Fig 0.2.
This dissertation analyzed the transcriptional profiles of P. aeruginosa in response to
L-arginine and D-arginine. The AruH and AruI were identified as an L-arginine: pyruvate
transaminase and a 2-ketoarginine decarboxylase, respectively. To our knowledge, this is
the first report of an arginine transaminase being characterized at the molecular level.
Based on these results, we proposed the arginine transaminase (ATA) pathway that
removes the α-amino group of L-arginine via transamination to replace the ADH
pathway as originally proposed. We also demonstrated the roles of the AruR and AruS
proteins in the regulation of the ATA pathway. Last, it is noteworthy that our recent DNA
microarray data strongly suggested that the PA3863 gene may encode a D-arginine
dehydrogenase.
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FIG. 0.1. Diagram of arginine structure and known catabolic reactions.
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FIG. 0.2. Predicted gene expression patterns of the arginine metabolic genes identified by
DNA microarray. WT, P. aeruginosa wild type strain PAO1; argR, P. aeruginosa argR
mutant strain PAO501; G, glutamate minimal medium P (MMP); G+A, glutamate MMP
with L-arginine. Illustrated are the arginine catabolic genes (square), the arginine
biosynthetic genes (circle) and the third type of genes (triangle).
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Chapter One
Functional Genomics Approach Enables the Identification of Genes of the Arginine
Transaminase Pathway in Pseudomonas aeruginosa

1.1 INTRODUCTION
Arginine utilization in pseudomonads can be mediated by multiple catabolic
pathways (Fig. 1.1). The arginine deiminase (ADI) pathway encoded by the arc operon
(Gamper et al., 1991; Haas, 1990; Vander Wauven et al., 1984) provides ATP to support
slow growth under anaerobic conditions. The arginine succinyltransferase (AST) pathway
encoded by the aru operon (Itoh, 1997) and the gdhB gene (Lu and Abdelal, 2001) is the
major route of arginine utilization as the carbon and nitrogen source under aerobic
conditions. The arginine decarboxylase (ADC) pathway may not contribute to arginine
utilization due to the lack of an arginine-inducible ADC activity, but rather serve to
supply putrescine when arginine is abundant (Itoh, 2004; Mercenier et al., 1980; Nakada
and Itoh, 2003). Nevertheless, exogenous agmatine or putrescine indeed can induce all
the enzymes following its entry point of the ADC pathway, and thus be utilized as the
sole source of carbon and nitrogen through this pathway (Haas et al., 1984; Lu et al.,
2002; Nakada et al., 2001).
The arginine dehydrogenase (ADH) pathway was considered as the second pathway
for arginine utilization in P. aeruginosa under aerobic conditions. This is supported by
the observation that while an aruF mutant without a functional AST pathway grew
poorly on arginine as the sole source of carbon and nitrogen, an aruF gbuA double
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mutant blocking both the AST and ADH pathways showed no growth on this amino acid
(Itoh, 2004). Although the kauB and gbuA genes encoding 4-guanidinobutyraldehyde
dehydrogenase and 4-guanidinobutyrase of the ADH pathway (Fig. 1.1) have been
identified or characterized (Holloway et al., 1994; Jann et al., 1988; Nakada and Itoh,
2002), genetic information for the initial steps of this pathway was completely
unavailable. While the presence of an L-arginine oxidase activity has been reported in P.
putida (Chou and Rodwell, 1972; Vanderbilt et al., 1975), this enzymatic activity has
never been demonstrated in P. aeruginosa. Instead, the presence of a D-arginine
inducible D-arginine dehydrogenase activity suggested an alternative route through this
enzyme and an arginine racemase in P. aeruginosa (Jann et al., 1988). Although the
removal of the α-amino group from L-arginine could be through either oxidative
deamination or transamination, the results of previous studies did not favor
transamination (Jann et al., 1988).
The ArgR protein, a transcriptional regulator of the AraC/XylS family (Gallegos et
al., 1997), controls arginine-dependent induction of the arc and aru operons and the gdhB
gene in P. aeruginosa (Lu and Abdelal, 2001; Lu et al., 1999; Park et al., 1997b). ArgR is
auto-induced by exogenous arginine from the aotJQMOP-argR operon for arginine and
ornithine uptake and regulation (Nishijyo et al., 1998). The ArgR protein also serves as
the repressor of the argF, argG, and carAB genes in arginine biosynthesis and the gdhA
and gltBD genes in glutamate biosynthesis (Hashim et al., 2004; Lu et al., 2004; Park et
al., 1997a; Park et al., 1997b). Over thirty genes of the ArgR regulon in P. aeruginosa
have been identified by transcriptome analyses (Lu et al., 2004). The kauB and gbuA
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genes of the ADH pathway were not identified as members of the ArgR regulon. In this
report, we conducted further transcriptome analyses to identify genes including kauB and
gbuA that are induced by exogenous L-arginine in the absence of ArgR. Identification of
genes encoding an arginine:pyruvate transaminase and a putative 2-ketoarginine
decarboxylase led us to propose that the α-amino group of L-arginine is removed via
transamination instead of oxidative deamination by dehydrogenase or oxidase as
originally proposed in the ADH pathway, and thus we proposed here to call this
reformulated route the arginine transaminase (ATA) pathway. In the same genetic locus,
we also identified a two-component system for the regulation of arginine-responsive
induction of the ATA pathway.

1.2 MATERIALS AND METHODS
1.2.1 Strains, plasmids, and growth conditions.
Major strains and plasmids used in this study are listed in Table 1.1. Luria-Bertani
(LB) enriched medium (Schweizer, 1991) was used for strain construction with the
following supplements as required: ampicillin, 50 µg/ml (for E. coli); carbenicillin, 100
µg/ml (for P. aeruginosa); gentamicin, 100 µg/ml; streptomycin, 500 µg/ml; and
tetracycline, 50 µg/ml. Minimal medium P (MMP) (Haas et al., 1977) was used for the
growth of P. aeruginosa PAO strains with supplements of specific carbon and nitrogen
sources at 20 mM as indicated.
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1.2.2 RNA isolation, generation of cDNA probes, and data analysis.
Total RNA was isolated using Qiagen RNeasy Kit, followed by DNase I treatment
and column RNA purification (Qiagen). Labeled cDNA probes were prepared in
accordance with the protocol provided by the manufacturer (Affymetrix). cDNA was
synthesized by annealing random primers (Invitrogen) to purified total RNA and
subsequent extension with reverse transcriptase (SuperScript II; Invitrogen). Spike RNAs
corresponding to B. subtilis genes dap, thr, phe, lys, and trp were included in the cDNA
synthesis reaction mixtures as an internal control to monitor the processes of labeling,
hybridization, and scanning efficiency.
The results of two independent experiments were merged for each of the following
three growth conditions: wild-type strain PAO1 in glutamate MMP (1E), wild-type strain
PAO1 in glutamate MMP plus L-arginine (1ER), and argR mutant strain PAO501 in
glutamate MMP plus L-arginine (5ER). The merged data were used for subsequent
comparisons and assessed with Microarray Suite 5.0 software (Affymetrix). Absolute
expression signal values were normalized for each chip by globally scaling to a target
intensity of 500. These data were imported into GeneSpring 6.1 software (Silicon
Genetics) for further analysis based on distinct expression patterns in these three
conditions. Transcripts with the absence call (P > 0.04) or with a signal level (5ER)
below 400 were eliminated.
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1.2.3 Construction of lacZ fusions.
Plasmid pQF52 (Park et al., 1997a), a broad-host-range lacZ translational fusion
vector, was used in the construction of promoter fusions of PA1421 (gbuA), PA2862
(lipA), PA3865, PA4980 and PA5304 (dadA). DNA fragments containing the regulatory
regions of interest were amplified by PCR from the genomic DNA of PAO1 with the
following synthetic oligonucleotides designed to generate HindIII restriction sites on the
forward primers: for PA1421 (gbuA), 5’-TTTAAGCTTCCAGTTCGCCGAGGATGCA
GCAG-3’ and 5’-CTGGTGGAGATTCTTGTCCACGGGGTGGCC-3’; for PA2862
(lipA), 5’-CCTAAGCTTCGCCCTGCCCTGCCCACCTCC-3’ and 5’-CTTCTTCATGT
TGTTCTCATCTCAGGTTGA-3’; for PA3865, 5’-AGCAAGCTTCCCCCATTACAGA
CGCGCCTC-3’

and

5’-GGTGTTCAGCGACTTGATCATGGACGACTC-3’;

for

PA4980, 5’-CCAAGCTTGGGCGACCCCGCCCTGGGACG-3’ and 5’-GGGGGAAAG
GTCAGTCATGCGGCC-3’; for PA5304 (dadA), 5’-AGAAAGCTTGCCGGGCAGTAC
GTCCAGGTC-3’ and 5’-CAGAACTCGCATTGTCGCCTCCCACGTCGC-3’. The
PCR products were purified from a 1% (wt/vol) agarose gel, digested by restriction
endonuclease HindIII, and ligated to the HindIII and SmaI sites of the translational fusion
vector pQF52. The resulting plasmids contain the entire upstream intergenic sequences of
the corresponding genes and the 5' ends of their coding sequences fused in-frame to the
eighth codon of the lacZ gene in the vector.
Another broad-host-range lacZ vector pQF50 (Farinha and Kropinski, 1990) was used
to produce the transcriptional fusion constructs of kauB and PA5313. Two different DNA
fragments were generated by PCR employing two oligonucleotide primers designed to
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generate HindIII restriction sites at both 5’ and 3’ ends of the PA5312 (kauB)-PA5313
intergenic region, 5’-CCGAAGCTTGAACTGGCGGTTGGCGGTGAA-3’ and 5’CACAAGCTTCGCCCTGCCCTGCCCACCTCC-3’. The PCR products were purified
from a 1% (wt/vol) agarose gel, digested by restriction endonuclease HindIII, and ligated
to the same site of the transcriptional fusion vector pQF50. Following the cloning strategy
described above, the resulting two fusion plasmids were designated pZY7 and pZY8,
respectively, which represent either PA5312 (kauB)::lacZ fusion or PA5313::lacZ fusion.
The nucleotide sequences of the resulting constructs were verified by nucleotide sequence
determination.

1.2.4 Construction of mutant strains.
The EZ::Tn5TM <TET-1> insertion system (Epicentre) was used for generation of
knockout mutations. The 11-kb HindIII fragment covering the aruRS-aruI cluster was
purified from cosmid pMO012227 (Pseudomonas Genetic Stock Center, PGSC) and
subcloned into the same site of the conjugation vector pRTP1 (Stibitz et al., 1986). The
resulting plasmid DNA was incubated with the transposase and the transposon with a
tetracycline resistance marker, and the in vitro transposon insertion reaction was carried
out under the conditions recommended by the manufacturer. After the reaction, the
mixture was used to transform E. coli DH5α, and transformants were selected on LB
plates with tetracycline. The insertion sites of mutant clones were mapped by HindIII
restriction endonuclease digestion and subsequently by nucleotide sequencing with a
transposon-specific flanking primer. For gene replacement, the resulting transposon
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insertion plasmids were first introduced into E. coli SM10 and then mobilized into the
spontaneous streptomycin-resistant P. aeruginosa strain PAO1-Sm and PAO4558-Sm by
biparental plate mating (Gamper et al., 1991). After incubation at 37°C overnight,
transconjugants were selected on LB plates supplemented with tetracycline and
streptomycin.
Knockout mutants of PA4975, PA4976 (aruH), and PA5304 (dadA) were also
constructed by using the similar strategy as described above. DNA fragments covering
those genes were generated by PCR from the genomic DNA of PAO1 with the following
synthetic oligonucleotides designed to generate HindIII restriction sites at both 5’ and 3’
ends

of

the

PCR

products:

for

PA4975

and

PA4976

(aruH),

5’-

GTCTAAGCTTGACTGGCCTGGCGCGCGTCG-3’ and 5’-CGCAAGCTTCGGGCAG
TCCGGCGTGACCCT-3’; for PA5304 (dadA), 5’-ACGGAAGCTTGGGCCGCCAGCA
TTTTTTA-3’ and 5’-ACCGAAGCTTTGGATATTTC CCGCTACAGC-3’. Genotypes
of all these constructed mutants were verified by Southern blot.

1.2.5 Complementation of aruH and aruI mutants.
The DNA fragment covering the PA4975 and aruH genes as described above was
cloned into the HindIII site of pUCP18. Expression of these two genes in the resulting
plasmid, pZY9, was under the control of the lac promoter. Competent cells of aruH and
aruI mutants of P. aeruginosa were prepared for transformation by pZY9 following the
standard protocols.
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1.2.6 Enzyme assays.
For the measurements of enzyme activities, cell cultures in the logarithmic phase were
collected by centrifugation, and the cell pellets were washed twice using 50 mM
potassium phosphate buffer, pH 7.0, and resuspended in the same buffer. Cells were
broken with a French pressure cell at 8,000 lb/in2, and soluble cell extracts were prepared
after centrifugation at 25,000 x g for 20 min. Protein concentration was determined by the
method of Bradford with bovine serum albumin as the standard (Bradford, 1976).
For the measurement of arginine:pyruvate transaminase activities, a two-step coupled
reaction was used as described in Chapter Two (Yang and Lu, 2007a). Briefly, the
reaction of arginine:pyruvate transamination generates 2-ketoarginine and alanine, and
the concentration of alanine was determined by monitoring the formation of NADH from
NAD+ in a coupled reaction with L-alanine dehydrogenase. In these reactions, anhydrous
hydrazine was used to trap the remaining substrate pyruvate as well as the reaction
product 2-ketoarginine as the hydrazones. Blanks did not contain L-arginine, pyruvate or
cell extract. One unit of enzyme activity is defined as the amount of the enzyme that
yielded 1 nmol of L-alanine per min under the standard assay conditions. The arginine
transaminase activity was linear for up to 15 minutes with less than 100 units of enzymes
in the first reaction.
Arginine oxidase was assayed by measuring the release of ammonia from L-arginine
in a coupled reaction with L-glutamate dehydrogenase under the conditions given by
Miller and Rodwell (Reitz and Rodwell, 1970). For the measurements of β-galactosidase
activity, o-nitrophenyl-β-D-galactopyranoside (ONPG) was used as the substrate (Miller,
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1972). Blanks did not contain crude extract. The molar extinction coefficient (4860 M1

cm-1) of ONPG at 420 nm was used for the calculation.

1.2.7 Detection of enzymatic products of AruI by HPLC.
An assay for 2-ketoarginine decarboxylase was reported previously (Miller and
Rodwell, 1971) by measuring the liberated
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CO2. Here we used HPLC to analyze this

enzymatic reaction. The reaction mixture contained, in a final volume of 0.3 ml: 100 mM
potassium phosphate (pH 7.5), 0.5 mM thiamine pyrophosphate (TPP), 1 mM MgSO4, 1
mM 2-ketoarginine, and crude extract (250 µg protein). The reaction was started by the
addition of crude extracts, and incubated at 37 °C for 1 h. In the negative control
experiments, heat-denatured crude extracts were used to prepare the reaction mixtures.
After incubation, the samples were boiled for 10 min and then filtered using an Ultrafree0.5 PBCC centrifugal filter unit (molecular mass cut-off 5 kDa; Millipore). After 10-fold
dilution (vol/vol) with deionized water, 30 µl of reaction samples were separated on a
Breeze HPLC system (Waters) equipped with a Develosil RP-Aqueous C30 column (4.6 ×
250 mm; Phenomenex) at a flow rate of 1 ml/min. The mobile phase was 0.1 M
potassium phosphate (pH 2.0), and elution was monitored by UV detection at 205 nm.
Authentic 2-ketoarginine, 4-guanidinobutyraldehyde (GUBAL) and TPP (Sigma) were
used as standards.
GUBAL was prepared as described by Tanaka et al (Tanaka et al., 2001). Briefly, LArginine hydrochloride monohydrate (100 mM) was exposed to a gentle flow of N2 for 5
min. An equimolar amount of chloramine T (Sigma) was added to the above L-arginine
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solution and incubated at 30°C for 1 h. The reaction byproduct, p-toluenesulfamide, and
the non-utilized chloramine T were crystallized by placing the reaction mixture in an ice
bath and then removed by filtration. The column (2.5×40 cm) of Dowex 50 (Bio-Rad
Laboratories) was washed and equilibrated with 1000 ml deionized water and the crude
preparation of 4-guanidinobutyraldehyde (80 ml) was then charged to the column. The
column was then washed with 500 ml of ion exchange water. L-Arginine was eluted with
2400 ml of 0.6 N HCl and then 4-guanidinobutyraldehyde with 2000 ml of 1.0 N HCl. 4Guanidinobutyraldehyde (800 ml) was neutralized with 3 N NaOH.
A protocol described by Jann et al was followed to prepare 2-ketoarginine (2-KA)
(Jann et al., 1988). L-Arginine hydrochloride monohydrate (9 mM) and n-octanol
(antifoam, 0.5 ml) were added to 45 ml 10 mM potassium phosphate buffer (pH 7.1)
containing 15 units of oxidase from Crotalus adamanteus (Sigma) and 60,000 units of
catalases (Sigma). The reaction mixture was exposed to a gentle flow of O2 and incubated
at 37 °C for 50 h or until the complete consumption of L-arginine. Using an Ultrafree-0.5
PBCC centrifugal filter unit (molecular mass cut-off 5 kDa; Millipore), the oxidase was
separated from the reaction mixture, and could be used two more times for 2-KA
synthesis. The reaction products were separated by column chromatography using Dowex
50-X8, H+ form (1.5×15 cm). Water, 0.1 M HCl and 1M HCl were used for elution. 2KA was obtained in 0.1 M HCl eluted fraction, and crystallized at 4 °C overnight.
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1.3 RESULTS
1.3.1 Identification of genes induced by L-arginine in the absence of ArgR.
To better understand arginine metabolism in P. aeruginosa, we have employed DNA
microarray to analyze the transcriptional profiles of this organism in response to Larginine. In the previous report (Lu et al., 2004), over thirty genes have been identified as
members of the ArgR regulon, in which gene expression is either repressed or activated
by exogenous L-arginine in the presence of a functional ArgR. These two groups of
genes exhibited distinct expression profiles, as represented by argF for the repression
group and aruF for the activation group (last two lanes; Table 1.2). In addition, ArgR
binding sites have been demonstrated in these genes. To our surprise, genes of the
proposed ADC and ADH pathways were not identified in the ArgR regulon. In this
report, we described a third type of expression profile in which genes were highly
induced by L-arginine in the argR mutant strain PAO501 but to a lesser extent in the wild
type strain PAO1 (Fig. 0.2).
Table 1.2 summarizes 38 genes in 18 putative transcriptional units falling into this
group. While many of these genes have not been characterized, it was interesting to note
the following three observations. Firstly, lipAH and PA4978-4980 genes are related to
lipid or fatty acid metabolism. Secondly, gabDT and spuIABC genes have been reported
inducible by agmatine or putrescine, and enzymes encoded by gabDT and spuC are part
of the ADC pathway. These genes as well as dadX-PA5303-dadA, PA5309, and kauBPA5313-PA5314 genes were indeed induced to a high level by agmatine or putrescine in
the wild type strain PAO1 from DNA microarray analysis. The kauB gene encodes a
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bifunctional dehydrogenase for 4-aminobutyraldehyde of the ADC pathway and 4guanidinobutyraldehyde (GUBAL) of the ADH pathway. Thirdly, the gbuA gene
encoding 4-guanidinobutyrase of the ADH pathway was also identified in this list. These
results suggested that genes of the convergent ADC and ADH pathways (Fig. 1.1) might
be cross-regulated, and that the genes for the first two steps of the ADH pathway yet to
be identified might also be in the same gene list.

1.3.2 Validation of microarray data by promoter::lacZ fusions.
Genes in Table 1.2 (also Fig. 1.4) could be categorized into 18 putative transcriptional
clusters. Promoters from seven of these clusters were selected for further analysis by lacZ
fusions: gbuA, lipA, PA3865, PA4980, dadA, kauB and PA5313. These promoter::lacZ
fusions were constructed as described in Materials and Methods, and the effect of ArgR
and exogenous L-arginine on expression of these promoters was analyzed by
measurements of β-galactosidase activities in PAO1 or the argR mutant harboring the
recombinant plasmids. As shown in Table 1.3, all these fusions exhibited 2 to 15 fold
higher L-arginine inducible promoter activities in the argR mutant than in the wild type
PAO1. Overall, these results correlated well with microarray data in the induction
pattern, and supported the presence of an additional arginine-responsive regulatory
mechanism besides that controlled by ArgR.
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1.3.3 The gbuA locus.
The gbuA gene (PA1421) encodes a guanidinobutyrase (Nakada and Itoh, 2002) for
the conversion of 4-guanidinobutyrate to 4-aminobutyrate in the proposed ADH pathway
(Fig. 1.1). It is the first gene of a putative 7-gene operon (PA1421-PA1415) as suggested
by the correlated expression profiles of these genes from microarray data (Table 1.2).
Among these genes, PA1416 and PA1417 were annotated to encode a FAD-linked
oxidase and a decarboxylase, respectively, which might catalyze the first two reactions of
the ADH pathway. Although our enzyme assay results for L-arginine oxidase did not
support the presence of L-arginine oxidase in P. aeruginosa, this possibility was further
explored by growth phenotype analysis of knockout mutants. As described in Materials
and Methods, inactivated PA1416 and PA1417 genes carrying a tetracycline-resistant
cassette were introduced by conjugation and homologous recombination to an aruF
mutant, devoid of the first enzyme of the AST pathway (Table 1.1). Growth of the aruF
mutant on L-arginine as the sole source of carbon and nitrogen was retarded, as
evidenced by a longer generation time than that of the wild type PAO1 (220 min versus
75 min). Disruption of PA1416 or PA1417 in the aruF mutant, however, exerted no
significant effect on L-arginine utilization, while in contrast disruption of gbuA abolished
growth on L-arginine. These results did not support the hypothesis that PA1416 and
PA1417 participate in the ADH pathway.
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1.3.4 The dadAX locus.
While the presence of an L-arginine oxidase activity was reported in P. putida, this
enzymatic activity has never been demonstrated in P. aeruginosa. Instead, a specific Darginine inducible D-arginine dehydrogenase was reported in P. aeruginosa PAO1 (Jann
et al., 1988), leading Jann and Haas to propose an alternative route for the ADH pathway
involving this enzyme and an arginine racemase (Fig. 1.1). The current genome
annotations (www.pseudomonas.com) designated PA5304 and PA5302 as dadA and
dadX (Table 1.2) based on the amino acid sequence similarity of the encoded proteins to
the catabolic D-alanine dehydrogenase and the alanine racemase of E. coli (Strych et al.,
2000), respectively. Since these two genes were induced by L-arginine, experiments were
conducted to test the hypothesis that they might encode the D-arginine dehydrogenase
and arginine racemase.
The effect of L-alanine, L-arginine and D-arginine on dadAX expression was studied
by measurements of β-galactosidase activities from the wild types strain PAO1 harboring
a dadA::lacZ fusion plasmid, pZY6. It was found that the promoter activity of dadA on
plasmid pZY6 was induced by L-alanine (950 µmol/min/mg) rather than by D-arginine
(52 µmol/min/mg) or by L-arginine (36 µmol/min/mg). L-Arginine, however, did exert a
moderate induction effect on the dadA promoter in the argR (121 µmol/min/mg) or aruF
(212 µmol/min/mg) mutant. In contrast, D-arginine only slightly induced the promoter
activity of dadA (88 µmol/min/mg), thus suggesting that DadAX might not be directly
involved in arginine catabolism.
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To investigate the role of DadA in arginine catabolism, dadA knockout mutants were
constructed in the wild type strain PAO1 or its aruF mutant. Disruption of dadA only
resulted in negligible decrease of D-arginine dehydrogenase activity. However, the dadA
aruF double mutant did not show growth (Table 1.5), while the dadA mutant grew well,
on L-arginine as the sole source of carbon and nitrogen.
These results would be those expected if, according to the gene annotations, the
dadAX genes encode a dehydrogenase and a racemase for alanine, but not for arginine. A
moderate level of induction effect by L-arginine to dadAX in an aruF mutant and the
abolishment of arginine utilization in a dadA aruF mutant would suggest a possibility
that the intracellular alanine pool was increased when L-arginine was supplemented to
the growth of the aruF mutant. Alanine could be a side product of arginine utilization via
an alternative pathway when the AST pathway is not available. However, none of the
proposed reactions in the ADH pathway would make alanine. It led us to propose that an
arginine:pyruvate transaminase, instead of arginine dehydrogenase or oxidase, catalyzes
the removal of α-amino group from L-arginine and makes alanine with pyruvate as the
amino group acceptor.

1.3.5 The aruIH locus.
As shown in Table 1.2, the contiguous PA4981-PA4975 genes were coordinately
induced to a high level by L-arginine in the argR mutant. Among these genes, PA4976
and PA4977 encode a putative class-I transaminase and thiamine pyrophosphatedependent decarboxylase, respectively. They could serve to catalyze the first two steps of
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our newly proposed arginine transaminase pathway. Knockout mutants of these seven
genes were constructed in an aruF mutant as described in Materials and Methods, and the
growth phenotype of these mutants on L-arginine was determined. The results showed
that disruption of PA4976 or PA4977 in the aruF mutant abolished the growth on Larginine as the sole source of carbon and nitrogen, and it showed no effect on glutamate
utilization. The effect of PA4976 and PA4977 on L-arginine utilization was only
observed in the aruF mutant but not in the wild type strain PAO1, thus suggesting the
enzymes encoded by those two genes might be directly involved in L-arginine utilization
when the AST pathway was blocked. PA4976 and PA4977 were designated as aruH and
aruI (arginine utilization) in accordance with their possible physiological functions.
Other genes in this locus encode proteins for energy metabolism (PA4975), lipid
metabolism (PA4980-PA4978) and amino acid transport (PA4981) as suggested by
genome annotations (Table 1.2). Except PA4979 encoding a putative acyl-CoA
dehydrogenase, the mutants of these genes in this locus grew on L-arginine indifferent
from the parent strain. It was noted that the lipAH operon encoding a lipase and a lipase
modulator was also induced by L-arginine in the argR mutant (Tables 1.2 & 1.3). These
results suggested an interesting link between L-arginine and lipid metabolism with
unknown physiological significance.
Expression of the aruIH genes could be from an L-arginine-inducible promoter
immediately upstream of PA4980 as demonstrated in Table 1.3. With no apparent rhoindependent terminator structure on the nucleotide sequence of this region, it is likely that
this detected promoter of PA4980 could serve to make a polycistronic transcript for

27

PA4980 to PA4975. In contrast, a rho-independent terminator was identified immediately
after the 3’-end of PA4981 coding sequence in the PA4981-PA4980 intergenic region. It
suggested the presence of another promoter for PA4981 yet to be identified.
The transposon used in construction of these mutants does not have any
transcriptional terminator structures at the flanking regions. Insertion of such a
transposon was not expected to have a polar effect on the expression of downstream
genes. Complementation by pZY9 carrying aruH only restored growth on L-arginine in
the aruF aruH mutant, but not the aruF aruI mutant. These results supported that
transposon insertion at aruI did not exert a polar effect on the downstream aruH gene,
and that both aruH and aruI were related to L-arginine utilization

1.3.6 AruH is an L-arginine:pyruvate transaminase.
Enzymatic measurements as described in Materials and Methods were conducted to
demonstrate the proposed L-arginine:pyruvate transaminase (ATase) activity of AruH. To
ensure that the production of alanine was from the transamination reaction between Larginine and pyruvate, we used the blanks which did not contain L-arginine, pyruvate or
crude extract. As shown in Table 1.4, an L-arginine inducible ATase activity was
detected in the aruF mutant when pyruvate was used as the amino group acceptor in the
reaction. This ATase activity was abolished when an aruH knockout was introduced to
the strain. While the ATase activity was induced at least 76 fold by L-arginine in the
aruF mutant, no arginine induction of this enzyme can be observed in the wild type strain
PAO1. These results supported the proposed biochemical function of AruH and its
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potential role in the ATA pathway as the second arginine catabolic pathway under
aerobic conditions. Detailed characterization of AruH was reported in Chapter Two
(Yang and Lu, 2007a).

1.3.7 AruI encodes a 2-ketoarginine decarboxylase.
Based on the results of sequence and growth phenotype analyses, we proposed that
AruI encodes a 2-ketoarginine decarboxylase catalyzing the second step of the ATA
pathway. To test this hypothesis, we set up the proposed decarboxylation reaction as
described in Materials and Methods with crude extracts of the aruF and aruF aruI
mutants grown in the minimal medium with glutamate and arginine as the carbon and
nitrogen sources, and the reaction components were analyzed by HPLC. As demonstrated
in Fig. 1.2, with the crude extract of the aruF mutant, consumption of 2-ketoarginine was
accompanied by generation of a new compound, presumably 4-guanidinobutyraldehyde
(GUBAL); more than 85% of 2-ketoarginine was converted into GUBAL in the reaction.
In contrast, only about 15% of substrate consumption was observed under the same assay
conditions with cell extract of the aruF aruI mutant. These results support our hypothesis
that AruI encodes a 2-ketoarginine decarboxylase.

1.3.8 Regulation of the ATA pathway by the AruRS two-component system.
The observation that genes listed in Table 2 were induced by exogenous L-arginine in
the argR mutant strongly suggested the presence of another arginine-responsive
regulatory system. Genes PA4982 and PA4983 encoding a sensor and a response
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regulator of a putative two-component system were located immediately upstream of the
aruIH locus. To investigate the potential role of this two-component system in regulation
of genes in the aruIH locus, knockout mutants of PA4982 and PA4983 were constructed,
and expression of the PA4980::lacZ fusion in the resulting mutants were analyzed by
measurements of β-galactosidase activities. As shown in Table 3, while L-arginine
exerted 5.8-fold and 17.8-fold of induction on the PA4980 promoter in wild type strain
and the argR mutant, respectively, this induction effect was abolished when either
PA4983 or PA4982 was disrupted regardless of ArgR. We therefore designated these two
genes as aruS (PA4982) and aruR (PA4983).
The effect of aruRS in arginine utilization was also studied by growth phenotype
analysis. It was found that disruption of either aruS or aruR in the aruF mutant prevented
growth on L-arginine. Furthermore, the arginine transaminase activities showed no
induction by L-arginine in the aruR mutant and a marginal induction in the aruS mutant
(Table 1.4). Similarly, the levels of kauB and gbuA promoter activities in these two
mutants were significantly reduced in the presence of L-arginine (Table 1.3). These
results demonstrated the essential role of AruRS in regulation of arginine transaminase
synthesis, hence the ATA pathway, in response to exogenous L-arginine.

1.3.9 Repression of the aruIH (PA4980) promoter activity by the addition of
succinate as a carbon source.
P. aeruginosa are well known for its metabolic versatility, which offers this organism
an extraordinary ability to utilize a wide range of organic compounds as carbon and/or
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nitrogen sources. In P. aeruginosa, expression of enzymes for the catabolic pathways of
these compounds is subjected to carbon catabolite repression (CCR), although the
mechanism is still unknown. Different from what is known in Escherichia coli and
Bacillus subtilis, glucose does not play the central role in CCR in P. aeruginosa. In
contrast, this organism preferentially metabolizes the tricarboxylic acid cycle
intermediates rather than other carbon sources. It has been reported that in P aeruginosa
the presence of succinate could repress the expression of enzymes of catabolic pathways
for various carbon sources including glucose and arginine.
Since genes of the aruIH locus are related to arginine catabolism, we tested whether
the expression of those genes also fell into CCR. The effect of succinate on the
expression of PA4980 promoter was analyzed by measurements of β-galactosidase
activities in P. aeruginosa PAO1 harboring the recombinant plasmids pZY5. As shown in
Table 1.6, while β-galactosidase expression from this PA4980::lacZ translational fusion
was induced when L-arginine served as a sole source of carbon and nitrogen, this
induction effect was strongly repressed (14.5 fold) when succinate was present in the
medium. In contrast, no significant change was observed in the addition of ammonium.

1.3.10 The effects of other amino acids on the promoter activity of the aruIH locus.
We found that expression of the aruIH genes could be from an L-arginine-inducible
promoter immediately upstream of PA4980. Also, we demonstrated that AruRS twocomponent regulatory system is essential for aruHI induction by L-arginine. We
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therefore thought that the regulation of the aruIH locus was likely to be arginine-specific,
although we do not know whether L-arginine per se is the induction signal of AruRS.
As shown in Chapter Two (Yang and Lu, 2007a), further characterization of AruH
showed that while L-arginine was found to be the best substrate among these amino
acids, this transaminase also exhibited the catalytic activity with less efficiency toward Llysine, L-methionine, L-leucine and ornithine. This result suggested that expression of the
aruIH genes might also be induced by those amino acids. To test this hypothesis,
expression of the PA4980::lacZ fusion was analyzed in P. aeruginosa strains PAO1 and
PA4558 by measurements of β-galactosidase activities. As shown in Table 1.7, ornithine
exerted 13.3-fold and 100.8-fold of induction on the PA4980 promoter in wild type strain
and its argF mutant, respectively. This was similar to what observed for L-arginine as we
expected because arginine and ornithine have very similar chemical structure. It was
noted that while lysine exerted 25.4-fold of induction on the PA4980 promoter in wild
type strain, this induction effect was not observed in the aruF mutant. We do not know
why the PA4980 promoter was induced by exogenous lysine in wild type strain and the
mechanism by which lysine induction effect was abolished in the aruF mutant. These
results suggested an interesting link between the genes of the aruIH locus and L-lysine
metabolism with unknown physiological significance.

1.4 DISCUSSION
Three lines of evidence that arose from this study led us to conclude that the ATA
pathway, instead of the ADH pathway, is the second pathway for L-arginine utilization in
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P. aeruginosa under aerobic conditions. Firstly, an L-arginine-inducible ATA was
encoded by the newly identified aruH gene. Secondly, disruption of aruH in a strain
devoid of a functional AST pathway abolished the ability of the resulting strain to utilize
L-arginine as the sole source of carbon and nitrogen. Thirdly, AruH utilizes pyruvate as
the amino group acceptor, and hence makes alanine, in the transamination reaction.
Recycling of pyruvate through the catabolic alanine dehydrogenase DadA is essential for
arginine utilization in the ATA pathway, as supported by the observation that the aruF
dadA mutant cannot grow on L-arginine as the sole carbon source. It is likely that in this
mutant, accumulation of alanine without recycling of pyruvate would drain the
intracellular pool of pyruvate and thus the carbon source provided by L-arginine through
the ATA pathway.
While no L-arginine dehydrogenase or oxidase activity has ever been demonstrated in
P. aeruginosa, the results of a previous study also did not favor the presence of an ATA.
It was based on the observation that arginine auxotrophs were not complemented by 2KA in the presence of L-alanine, assuming that L-arginine would be generated by these
two substrates in the reverse reaction of arginine transamination. It was very likely that
the proposed reverse reaction never happened, for the following reasons. The ATA may
not be expressed in the arginine auxotrophs in the absence of arginine. Even if the
enzyme were expressed, 2-KA and L-alanine might not be available at a concentration
high enough to drive the reverse reaction. Alanine could induce the expression of DadX
and DadA and thus be converted into pyruvate. Also, it has been reported in the same
study that 2-KA induced GbuA, suggesting catabolism of 2-KA into 4-guanidinobutyrate
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(Nakada and Itoh, 2002). In addition, as reported in Chapter Two (Yang and Lu, 2007a),
no L-arginine synthesis can be detected by HPLC in the reverse reaction with purified
AruH under the assay conditions used.
In comparison, the AST pathway is more efficient than the ATA pathway in many
aspects. First, it is more efficient in terms of L-arginine affinity. The Km of L-arginine is
0.5 mM to AST AruF (Tricot et al., 1991) and 14 mM to ATA AruH (Itoh, 1997).
Second, it is more efficient in terms of gene organization and regulation. The genes that
encode enzymes of the AST pathway are organized into the aru operon and the gdhB
gene, and they are controlled by a single regulator, ArgR. Genes of the ATA pathway are
most likely grouped into several regulatory modules in response to different intermediate
compounds that were also involved in polyamine catabolism (Haas, 1990). We found in
this study that the AruRS two-component regulatory system is essential for aruHI
induction by L-arginine; however, whether L-arginine per se is the induction signal of
AruRS remained to be elucidated. Without a functional ArgR protein, it is known that the
AST pathway and L-arginine uptake would be severely hampered. It has been reported
that blocking of the AST pathway alone is sufficient to render enzymes of the ATA
pathway inducible by L-arginine (Itoh, 2004; Jann et al., 1988). Perhaps N2-succinyl-Larginine or its derivatives of the AST pathway might serve as an antagonistic signal to
block the AruRS system, and subsequently expression of the less efficient ATA pathway,
when the AST pathway is available.
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The kauB and gbuA genes of the ATA pathway could be controlled by a regulatory
module different from ArgR and AruRS. The gbuA gene has been reported to be
regulated by GbuR, a transcriptional activator of the LysR family, in the presence of 4guanidinobutyrate (Nakada and Itoh, 2003). It was still not clear how kauB was regulated,
as this gene encodes a bifunctional enzyme in the ADC and ATA pathways (Jann et al.,
1988). As mentioned earlier, putrescine and spermidine exerted a stronger induction
effect on the expression of kauB than L-arginine. It was possible that a common
regulatory mechanism could be shared by kauB and other genes involved in polyamine
metabolism.
The gene organization of the aruHI locus in P. aeruginosa PAO1 was found to be
highly conserved in P. putida KT2440 and Pseudomonas fluorescens Pf-1, as shown in
Fig. 1.3. Given the proven functions of AruIH in the ATA pathway of P. aeruginosa and
the conserved gene organization, it is very likely that the ATA pathway also contributes
to L-arginine utilization in P. fluorescens and P. putida. Although an L-arginine oxidase
activity has been reported in P. putida P2 (Chou and Rodwell, 1972; Vanderbilt et al.,
1975), we were unable to detect this enzyme activity in P. putida KT2440. However, it
was noted that the reading frame of P. putida AruI was interrupted by a termination
codon in its coding sequence. Furthermore, PP3722, which encodes a putative amino acid
racemase, was located between aruI and aruH in this organism. More work is required to
answer the question of 2-KA synthesis in P. putida.
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As evidenced in Chapter Two (Yang and Lu, 2007a), we concluded that AruH is not
the homologue of E. coli AspC (Fotheringham et al., 1986), an aspartate transaminase for
aspartate biosynthesis, as was initially described in the Pseudomonas genome annotation.
With E. coli AspC as the template to search against the PAO1 genome, the results of a
BLAST search showed that PA3139 and PA0870 are the two most prominent candidates.
However, PA0870 was annotated as PhhC, which has been reported as an essential
transaminase for tyrosine and phenylalanine catabolism (Stover et al., 2000). Therefore, it
is likely that PA3139 is the biosynthetic aspartate transaminase. Similarly, the AruI
protein was demonstrated by HPLC analysis in this study to catalyze the decarboxylation
reaction of 2-KA in the ATA pathway and is not likely the homologue of E. coli
acetolactate synthase IlvB (Friden et al., 1985), as suggested by genome annotation.
Instead, PA4696 is the most likely candidate on the basis of its 77% sequence similarity
to E. coli IlvB. Moreover, it was noted that AruI exhibited 57% similarity to another
putative TPP-dependent decarboxylase encoded by PA1417, which was also identified in
this study as a gene inducible by L-arginine in the absence of ArgR. While the
physiological function of PA1417 remained unknown, it was intriguing to speculate that
it might be responsible for the observed residual 2-KA decarboxylase activity in the aruF
aruI mutant (Fig. 1.2).
In this study, we have ruled out the significance of D-arginine-inducible D-arginine
dehydrogenase (Jann et al., 1988) in L-arginine utilization; however, this yet-to-beidentified enzyme could still provide an alternative route for D-arginine utilization. We
have observed that D-arginine utilization was partially retarded in the aruF mutant devoid
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of the AST pathway, and blocking of the ATA pathway in this mutant by either aruH or
aruI did not result in further inhibition of growth on D-arginine. To be utilized by the
AST pathway, D-arginine is supposed to be converted into L-arginine by a racemase, as
D-arginine is a competitive inhibitor of AST catalyzing the first reaction of the AST
pathway (Tricot et al., 1991). The physiological functions of arginine racemase and Darginine dehydrogenase in arginine metabolism warrant further investigation.
In conclusion, the complexity of arginine metabolism in P. aeruginosa was fully
illustrated in our previous report (Lu et al., 2004) and in this study employing DNA
microarray analyses. While some of these discoveries have apparent linkages to arginine
metabolism, many of the newly identified avenues remained interesting topics to explore.
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TABLE 1.1. Bacterial strains and plasmids used in this study.
Genotype or descriptiona

Source or
Reference
Bethesda Research
Laboratories

SM10

F
80dlac M15
(lacZYA-argF)U169 deoR recA1 endA1
hsdR17(rK mK ) supE44 thi-1 gyrA96 relA1
thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (Kmr)

P. aeruginosa
PAO1
PAO501
PAO1-Sm
PAO4558
PAO4558-Sm
PAO4566
PAO5508
PAO5509
PAO5601
PAO5602
PAO5603
PAO5604
PAO5605
PAO5606
PAO5607
PAO5608
PAO5609
PAO5610
PAO5018
PAO5019

Wild type
argR::Gm
Spontaneous Smr of PAO1
aruF
Spontaneous Smr of PAO4558
aruF gbuA
aruS::Tc
aruR::Tc
PA4975::Tc aruF
aruH::Tc aruF
aruI::Tc aruF
PA4978::Tc aruF
PA4979::Tc aruF
PA4980::Tc aruF
PA4981::Tc aruF
aruS::Tc aruF
aruR::Tc aruF
dadA::Tc aruF
aruS::Tc argR::Gm
aruR::Tc argR::Gm

Strain or plasmid
Strains
E. coli
DH5α

Plasmids
pQF50
pQF52
pRTP1
pUCP18
pZY1
pZY2
pZY4
pZY5
pZY6
pZY7
pZY8
pZY9
pMO012222
pMO012227
pMO011841
a

bla lacZ transcriptional fusion vector
bla lacZ translational fusion vector
Apr Strs conjugation vector
E. coli-P. aeruginosa shuttle vector
gbuA::lacZ translational fusion of pQF52
lipA::lacZ translational fusion of pQF52
PA3865::lacZ translational fusion of pQF52
PA4980::lacZ translational fusion of pQF52
dadA::lacZ translational fusion of pQF52
kauB::lacZ transcriptional fusion of pQF50
PA5313::lacZ transcriptional fusion of pQF50
An aruI PA4975 clone in pUCP18
Cosmid clone containing PA1415-PA1417 gene cluster in
pLA2917; Tcr
Cosmid clone containing aruRS-aruH gene cluster in pLA2917;
Tcr
Cosmid clone containing dadA gene in pLA2917; Tcr

Gm, gentamicin; Sm, streptomycin; Tc, tetracycline; Km, kanamycin.

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
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TABLE 1.2. Microarray analysis of genes induced by L-arginine in the absence of ArgR
in P. aeruginosa.
Gene no.a
*PA0265
*PA0266
*PA0296
*PA0297
*PA0298
*PA0299
PA1415
PA1416
PA1417
PA1418
PA1419
PA1420
PA1421
PA2310
PA2311
PA2312
PA2313
PA2862
PA2863
PA3690
PA3862
PA3863
PA3864
PA3865
PA4975
PA4976
PA4977
PA4978
PA4979
PA4980
PA4981
*PA5302
*PA5303
*PA5304
*PA5309
*PA5312
*PA5313
*PA5314
PA3537
PA0896
a

Gene
name
gabD
gabT
spuI
spuA
spuB
spuC

gbuA

lipA
lipH

aruH
aruI

dadX
dadA
kauB

argF
aruF

Protein description
Succinate-semialdehyde dehydrogenase
4-Aminobutyrate aminotransferase
Glutamine synthetase homologue
Glutamine amidotransferase
Glutamine synthetase homologue
Putrescine aminotransferase
Unknown
FAD linked oxidase
Decarboxylase
Transport of small molecules
Transport of small molecules
Unknown
Guanidinobutyrase
Unknown
Unknown
Transcriptional regulator
Unknown
Lactonizing lipase precursor
Lipase modulator protein
Metal transporting P-type ATPase
Unknown
Unknown
Unknown
Amino acid binding protein
NAD(P)H quinone oxidoreductase
Arginine: pyruvate transaminase
2-Ketoarginine decarboxylase
Pimeloyl-CoA synthetase
Acyl-CoA dehydrogenase
Enoyl-CoA hydratase/isomerase
Transport of small molecules
Alanine racemase
Unknown
D-Alanine dehydrogenase
Oxidoreductase
4-Guanidinobutyraldehyde dehydrogenase
Pyridoxal-dependent aminotransferase
Unknown
Ornithine carbamoyltransferase
Arginine succinyltransferase

Absolute signal valueb
PAO1 (E) PAO1 (ER)
332
707
712
1,192
1,018
1,301
186
687
514
1,166
869
1,902
118
131
49
11
68
149
152
128
43
72
47
151
66
46
68
114
525
1,379
150
339
70
87
760
451
127
77
162
426
84
245
56
265
257
418
174
498
98
225
61
192
59
149
69
177
77
17
97
687
57
573
26
85
81
162
88
113
413
651
780
1,111
150
386
123
397
874
181
174
4,054

PAO501 (ER)
4,227
5,606
4,505
2,866
3,872
5,620
946
377
531
1,748
1,015
1,357
954
579
8,153
1,424
190
3,871
606
8,550
772
602
953
3,558
2,635
2,639
3,977
2,998
3,435
7,154
12,235
408
571
643
1,878
4,774
1,449
1,646
1,444
59

Gene numbers are from the Pseudomonas Genome Project (www.pseudomonas.com).
Genes that were also induced by agmatine, putrescine and spermidine were marked with
asterisks. The expression profiles of argF and aruF at the end of this list represented
ArgR-dependent repression and activation, respectively.
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b

Abbreviations: E, cells were grown in glutamate minimal medium P (MMP); ER, cells
were grown in glutamate MMP supplied with 20 mM L-arginine.
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TABLE 1.3. Verification of microarray data by promoter-lacZ fusions.

PAO1 (wild type)
PAO501 (argR)
PAO4558 (aruF)
PAO5608 (aruF, aruS)
PAO5609 (aruF, aruR)

Sp act (µmol/min/mg)b
Glu
Glu+Arg
9
18
7
216
11
177
9
26
12
37

2.0
30.9
16.1
2.9
3.1

PA2862 (lipA)

PAO1 (wild type)
PAO501 (argR)

107
251

68
963

0.6
3.8

PA3865

PAO1 (wild type)
PAO501 (argR)

823
664

208
2,156

0.3
3.2

PA4980

PAO1 (wild type)
PAO501 (argR)
PAO5508 (aruS)
PAO5509 (aruR)
PAO5018 (argR aruS)
PAO5019 (argR aruR)
PAO4558 (aruF)
PA5608 (aruF aruS)
PAO5609 (aruF aruR)

1,241
1,643
1,069
251
1,158
942
145
177
101

7,216
29,191
998
355
2,217
824
22,899
1,547
635

5.8
17.8
0.9
1.4
1.9
0.9
157.9
8.7
6.3

PA5304 (dadA)

PAO1 (wild type)
PAO501 (argR)

30
47

36
121

1.2
2.6

PA5312 (kauB)

PAO1 (wild type)
PAO501 (argR)
PAO4558 (aruF)
PAO5608 (aruF aruS)
PAO5609 (aruF aruR)

111
116
102
9
4

136
266
234
21
12

1.2
2.3
2.3
2.3
3

PA5313

PAO1 (wild type)
PAO501 (argR)

254
178

335
677

1.3
3.8

Gene no.
(name)a
PA1421 (gbuA)

a

Host strain (genotype)

Fold changec

Gene numbers and names are from the Pseudomonas Genome Project
(www.pseudomonas.com).
b
Specific activities are average of three measurements for each growth condition, with
standard errors of less than 5%. Glu, cells were grown in glutamate minimal medium P
(MMP); Glu+Arg, cells were grown in glutamate MMP supplied with 20 mM L-arginine.
c
Fold changes of gene expression are indicated by the ratio of cells grown in glutamate
MMP in the presence of arginine to cells grown in glutamate MMP in the absence of
arginine.
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TABLE 1.4. Measurements of L-arginine transaminase activities in P. aeruginosa PAO1
and its mutant strains.
Strains (Genotype)
PAO1 (wild type)
PAO4558 (aruF)
PA5602 (aruH aruF)
PA5608 (aruS aruF)
PA5609 (aruR aruF)
a

Sp acta (nmol/min/mg)
Glu
Glu + Arg
<0.5
<0.5
<0.5
38
<0.5
<0.5
<0.5
3
<0.5
<0.5

Cells were cultured to mid-log phase (OD600 = 0.5) in MMP-glutamate medium with or
without L-arginine. Cell extracts preparation and the enzyme assays were described in
Materials and Methods.
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TABLE 1.5. Growth of P. aeruginosa PAO1 and its mutant strains on L-arginine.
Strain
Genotype
Doubling time (min)a
PAO1
Wild type
75
PAO501
295
argR
PAO4558
221
aruF
PAO4562
275
aruF aguAB
PAO4566
NG
aruF gbuA
PAO5602
NG
aruF aruH
PAO5603
NG
aruF aruI
PAO5605
aruF PA4979
NG
PAO5608
NG
aruF aruS
PAO5609
NG
aruF aruR
PAO5610
NG
aruF dadA
a
Cell growth was tested in MMP containing 20mM L-arginine as sole carbon and
nitrogen sources. NG, no growth.
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TABLE 1.6. Measurements of β-galactosidase activity in P. aeruginosa strains PAO1
harboring PA4980::lacZ translational fusion plasmid pZY5.
Growth conditionsa
Suc+NH4+
Suc+Arg
Arg+NH4+
Arg
a

Sp act (monomers/103 cells)b
1.1
1.5
19.4
21.7

Abbreviations: Arg, cells were grown in arginine minimal medium P (MMP); Suc+Arg,
cells were grown in arginine MMP supplied with 20 mM succinate; Arg+NH4+, cells
were grown in arginine MMP supplied with 20 mM NH4Cl; Suc+NH4+, cells were grown
in MMP supplied with 20 mM succinate and 20 mM NH4Cl.
b
Enzyme sufficient to produce 1 OD420nm per min is 4.45 x 1012 monomers.
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TABLE 1.7. Measurements of β-galactosidase activity in P. aeruginosa strains PAO1
and PAO4558 harboring PA4980::lacZ translational fusion plasmid pZY5.
Host strains (genotypes) and growth conditionsa
PAO1 (wild type)
Glu
Glu + Arg
Glu + Lys
Glu + Met
Glu + Leu
Glu + Orn
PAO4558 (aruF)
Glu
Glu + Arg
Glu + Lys
Glu + Met
Glu + Leu
Glu + Orn
a

Sp act (µmol/min/mg)
893
11,963
22,675
961
931
11,865
189
25,775
642
415
326
19,051

Abbreviations: Glu, cells were grown in glutamate minimal medium P (MMP);
Glu+Arg, cells were grown in glutamate MMP supplied with 20 mM L-arginine;
Glu+Lys, cells were grown in glutamate MMP supplied with 20 mM L-lysine; Glu+Met,
cells were grown in glutamate MMP supplied with 20 mM L-methionine; Glu+Leu, cells
were grown in glutamate MMP supplied with 20 mM L-leucine; Glu+Orn, cells were
grown in glutamate MMP supplied with 20 mM L-ornithine.
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FIG. 1.1. Arginine catabolic pathways in P. aeruginosa PAO1. Only relevant
intermediates and genes are indicated. ADI, arginine deiminase pathway; AST, arginine
succinyltransferase pathway; ADC, arginine decarboxylase pathway; ATA, arginine
transaminase pathway; TCA, tricarboxylic acid. Also illustrated were two more routes for
2-ketoarginine synthesis: arginine racemase/D-arginine dehydrogenase in P. aeruginosa
PAO1 (ADH) and L-arginine oxidase in P. putida P2 (AO). aruF, arginine
succinyltransferase; aruH, arginine transaminase; aruI, 2-ketoarginine decarboxylase;
gabD, 4-aminobutyraldehyde dehydrogenase; gabT, 4-aminobutyrate transaminase;
gbuA, 4-guanidinobutyrase; kauB, 4-guanidinobutyraldehyde/4-aminobutyraldehyde
dehydrogenase.
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FIG. 1.2. HPLC analysis of the AruI reaction products. Chromatograms of components of
the reaction mixture at 205 nm either with heat-inactivated crude extracts (the aruF
mutant, dashed gray line; the aruF aruI mutant, solid gray line) or active crude extracts
(the aruF mutant, solid black line; the aruF aruI mutant, dashed black line) were
recorded as described in Materials and Methods. Signal peaks for thiamine
pyrophosphate (TPP), 2-ketoarginine (2-KA) and 4-guanidinobutyraldehyde (GUBAL)
were individually identified, according to their same retention times as of authentic
reference compounds. In this system, retention times for TPP, 2-KA and GUBAL were
4.0 min, 5.9 min and 7.5 min, respectively. Traces are shown offset vertically and A205
values are given in arbitrary units.
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FIG. 1.3. Conserved gene organization of the aruRS-aruIH locus in pseudomonads. Functions of the aru genes in this locus of
P. aeruginosa were reported in this study, and the same gene designations were given to their counterparts in P. putida and P.
fluorescens based on sequence similarities. Other genes in the locus were numbered according to each individual genome
annotation projects. Regulatory genes are marked with filled arrows; the differences of two genes in P. aeruginosa and three
genes in the other two species were most likely due to reading frame shift by point mutations in the nucleotide sequences. The
additional gene 3722 of P. putida encoding a putative amino acid racemase was unique only in this organism. Also presented
were locations of transposons carrying a tetracycline-resistance cassette (Tet) in the mutants of P. aeruginosa as described in
the text. Open and filled triangles represent Tet in the same and reverse orientations of the inserted genes, respectively.
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FIG 1.4. Microarray analysis of genes induced by L-arginine in the absence of ArgR in P. aeruginosa, including known genes
of the ATA pathway (orange), putative enzyme encoding genes (grey), putative transporter genes (green) and unknown genes
(black). Fold changes were calculated based on the absolute signal values of DNA microarray.
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Chapter Two
Characterization of an Arginine:Pyruvate Transaminase in Arginine Catabolism of
Pseudomonas aeruginosa PAO1

2.1 INTRODUCTION
Arginine utilization in pseudomonads as the sole source of carbon and nitrogen can
be mediated by multiple catabolic pathways. The arginine succinyltransferase (AST)
pathway is the major route of arginine catabolism under aerobic conditions (Haas, 1990;
Stalon et al., 1987). In the absence of a functional AST pathway, growth on L-arginine
remained but was retarded (Itoh, 2004; Tricot et al., 1991). It has been reported that the
arginine oxidase pathway is the second route of L-arginine utilization in P. putida (Miller
and Rodwell, 1971; Tricot et al., 1991). While the arginine oxidase activity has never
been demonstrated in P. aeruginosa, the presence of D-arginine dehydrogenase and
arginine racemase activities provided an alternative route for L-arginine utilization by
this organism (Jann et al., 1988). Oxidative deamination of arginine by arginine oxidase
or dehydrogenase produces 2-ketoarginine, which is subsequently catabolized into
succinate by a series of reactions common to both organisms.
Synthesis of 2-ketoarginine from L-arginine can also be accomplished by the
transamination reaction (Tachiki et al., 1980). In Chapter One (Yang and Lu, 2007b), we
reported an arginine-inducible arginine transaminase (ATA) activity in P. aeruginosa
PAO1, and this activity was completely abolished when the aruH gene was deleted. The
aruH gene was proposed to encode a putative ATA residing in a multi-gene operon,
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which is highly conserved in P. aeruginosa, P. putida, and P. fluorescens (Yang and Lu,
2007b).
In the present study, we purified the His-tagged AruH protein from E. coli and
characterized its enzymatic properties. Evidence was provided herein that AruH indeed
catalyzes a transamination reaction with pyruvate as the amino acceptor, following a
Ping-Pong Bi Bi kinetics model. When L-arginine was used as the amino donor, the
products of this transamination reaction, 2-ketoarginine and L-alanine, were confirmed
by HPLC and MS, and the kinetic properties were analyzed by a coupled reaction with
NAD+ and L-alanine dehydrogenase.

2.2 MATERIALS AND METHODS
2.2.1 Expression of aruH in E. coli.
The pBAD protein expression system by arabinose induction (Invitrogen) was
employed for overproduction of AruH. The aruH structural gene was amplified by PCR
from the genomic DNA of P. aeruginosa PAO1 using the following two primers to
introduce an 6×His tag at the N-terminus: 5’-CCGTCATGAGACATCATCATCATCAT
CATATGCGCTATTCCGACTTCA-3’ and 5’-AATCTGCAGTCAGGCCTGGCCGAG
CAACTC-3’. The resulting PCR product was digested with BspHI (NcoI compatible) and
PstI, which are unique restriction sites flanking the PCR product as introduced by the
primers, and cloned into the NcoI and PstI sites of the expression vector pBAD-HisA.
The resulting plasmid, pYZNH3, was introduced into E. coli Rosetta (DE3) pLysS (EMD
Bioscience). For overexpression of aruH, the recombinant strain of E. coli was grown in
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LB medium containing ampicillin (100 µg/ml) and chloramphenicol (30 µg/ml) at 22°C
until the optical density at 600 nm reached 0.5, at which point 0.2% arabinose (w/v; final
concentration) was added to the culture for induction. The culture growth was continued
for another 18 h under the same conditions, and cells were harvested by centrifugation.

2.2.2 Purification of His6-tagged AruH.
Recombinant AruH was purified using a HisTrap HP kit (GE Healthcare) according
to the manufacturer’s instructions. Briefly, the cell pellet (approximately 10 g) was
suspended in 20 ml phosphate buffer (20 mM sodium phosphate, 500 mM NaCl, 20 mM
imidazole, pH 7.4). EDTA-free protease inhibitor cocktail (2 tablets; Roche) was added,
and the cells were ruptured by an Aminco French pressure cell at 8,000 lb/in2. The cell
debris was removed by centrifugation at 25,000 × g for 30 min, and the resulting cell-free
crude extract was applied onto a HisTrap HP column (GE Healthcare) equilibrated with
the same sodium phosphate buffer as described above. After washing away the unbound
proteins with equilibration buffer, His-tagged AruH was eluted with a stepwise gradient
of 150 mM imidazole in 20 mM phosphate (pH 7.4) and 500 mM NaCl. For further
purification, AruH proteins were subjected to anion exchange chromatography using a
Mono Q HR 5/5 column (Pharmacia) equilibrated with 20 mM Tris/HCl (pH 7.4; buffer
A). Protein sample was applied to the column and eluted with buffer A followed by a
linear gradient of 0-1 M KCl in buffer A over 20 column volumes. Active fractions that
were homogenous as determined by visual inspection of SDS-PAGE gels were pooled,
and then desalted and concentrated using an Aminco Ultra-15 centrifugal filter unit
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(molecular mass cut-off 30 kDa; Millipore). UV/visible absorption spectra of the purified
protein (8 mg/ml) in buffer A were recorded at 25°C with a Cary 3E spectrophotometer
(Varian). Aliquots of AruH, supplemented with 50 µM pyridoxal 5’-phosphate (PLP) and
EDTA-free protease inhibitor cocktail, were stored at 4°C before usage for enzyme
assays (up to 1 week storage).

2.2.3 Gel filtration analysis.
Gel filtration was performed with low molecular weight (LMW) and high molecular
weight (HMW) calibration kits (GE Healthcare), using a Superdex 200 HR 10/30 column
(GE Healthcare) equilibrated with 50 mM sodium phosphate (pH 7.4) containing 300
mM NaCl. The recombinant AruH (50 µl; 5 mg/ml) was injected to the column and
eluted at a flow rate of 0.5 ml/min. Molecular mass standards used were thyroglobulin
(669 kDa), catalase (232 kDa), aldolase (158 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa) and chymotrypsinogen A (25 kDa).

2.2.4 Identification of 2-ketoarginine as a product of the AruH reaction by HPLC.
A reaction mixture (1.0 ml) containing 10 µg of recombinant AruH, 20 mM Larginine, 20 mM pyruvate, 0.5 mM PLP in 70 mM Tris/HCl buffer (pH 9.0) was
incubated for 1 h at 37°C. After incubation, the sample was boiled for 10 min and then
filtered using an Ultrafree-0.5 PBCC centrifugal filter unit (molecular mass cut-off 5
kDa; Millipore). In a negative control experiment, heat-denatured recombinant AruH was
used to prepare the reaction mixture. Reaction samples were separated on a Breeze HPLC
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system (Waters) equipped with a Develosil RP-Aqueous C30 column (4.6 × 250 mm;
Phenomenex) at a flow rate of 1 ml/min. The mobile phase was 0.1 M potassium
phosphate (pH 2.0), and elution was monitored by UV detection at 205 nm. Authentic Larginine, pyruvate, PLP and 2-ketoarginine were used as standards. A protocol described
by Jann et al (Jann et al., 1988) was followed to prepare 2-ketoarginine.
For the reversible reaction, 20 mM 2-ketoarginine and 20 mM L-alanine were used as
substrates to replace 20 mM L-arginine and 20 mM pyruvate using the same method as
described above, followed by HPLC analysis.

2.2.5 Mass spectrometry of the AruH reaction products.
Samples prepared as described above for HPLC analysis were submitted for
electrospray ionization mass spectrometry (ESI-MS) analysis in Mass Spectrometry
Facility at Georgia State University. In the L-lysine experiments, 20 mM L-lysine was
used to replace 20 mM L-arginine as the amino donor. The samples were diluted with
MeOH (1:1, v/v) and introduced to a Q-Tof micro MS (Waters) for analysis using
negative mode by infusion injection at flow rate of 5 µl/min, with a capillary voltage of
3.5 kV, a sample cone voltage of 25 V and an extract cone voltage of 1.0 V.

2.2.6 Enzyme assays.
The arginine:pyruvate transaminase activity of the recombinant AruH was measured
in two steps. The first step was a transamination reaction catalyzed by recombinant
AruH, in which α-amino group of L-arginine was transferred to pyruvate, making
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therefore 2-ketoarginine and L-alanine. In the second step, the amounts of L-alanine
formed in the transamination reaction were determined using an enzyme coupled reaction
as previously described (Yang and Lu, 2007b), in which L-alanine was oxidized to
pyruvate and ammonia in the presence of NAD+ and L-alanine dehydrogenase.
Briefly, the assay mixture I (1.0 ml; final volume) contained 20 mM L-arginine, 20
mM pyruvate, 0.5 mM PLP and 70 mM Tris/HCl (pH 9.0), unless otherwise noted. The
assay mixture I was pre-incubated for 10 min at 37°C prior to the addition of 10 µg of
recombinant AruH by which the reaction was started. A 4-min incubation period at 37°C
consumed <10% of the substrates. The reaction was stopped by the addition of 50 µl
anhydrous hydrazine (Sigma) which trapped the remaining substrate pyruvate (also
reaction product 2-ketoarginine) as the hydrazones. The protein precipitates were
removed by centrifugation after the assay mixture I was boiled for 10 min. Blanks did not
contain L-arginine, pyruvate or recombinant AruH. The reaction I was linear with
incubation of assay mixture up to 5 minutes and enzyme concentration up to 20 µg/ml.
For the second step, the assay mixture II (2.1 ml) contained 1ml hydrazine/Tris buffer
(hydrazine, 1.0 M; Tris base, 40 mM; EDTA, 1.4 mM; adjusted to pH 9.0 with HCl), 1.2
mM NAD+ and supernatant from reaction I (0.1-0.8 ml containing 10-100 µM L-alanine).
The assay reaction II was started by the addition of 2 units of L-alanine dehydrogenase
(Sigma), and the increase of the absorbance at 339 nm was monitored at 25°C until no
significant increase could be detected. The molar extinction coefficient (6300 M-1cm-1) of
NADH was used for the calculation. One unit of enzyme activity is defined as the amount
of the enzyme that yielded 1 µmol of L-alanine per min under the standard assay
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conditions as described above. The reaction II with L-alanine dehydrogenase is specific
for L-alanine determination and linear over the range of 5-300 µM L-alanine
(Williamson, 1985). The protein concentration was determined by the method of
Bradford (Bradford, 1976) with bovine serum albumin as the standard.

2.2.7 Kinetic studies.
Kinetic assays were performed using the two-step assay method as described above
with various concentrations of L-arginine (the amino donor, 2.0-10.0 mM) and pyruvate
(the amino acceptor, 0.3-2.0 mM). Using the kinetics module of SigmaPlot (SigmaPlot
2004 for Windows Version 9.01, SPSS Science), apparent kinetic parameters were
determined by fitting data to the equations for sequential and ping-pong steady state
mechanisms, respectively.

2.2.8 Substrate specificity.
Substrate specificity was investigated by the same assay method as described above,
replacing 20 mM of L-arginine with various L-amino acids as the amino donor or
replacing 20 mM pyruvate with 20 mM 2-ketoglutarate as the amino acceptor. When 2ketoglutarate was used as the amino acceptor in the reaction, synthesis of L-glutamate
was measured by monitoring the formation of NADH from NAD+ in a coupled reaction
with L-glutamate dehydrogenase (Beutler, 1985). Anhydrous hydrazine (Sigma) was
used to trap remaining substrate 2-ketoglutarate, similar to that used for the
arginine:pyruvate transaminase assay.
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2.2.9 pH and temperature studies.
For the pH studies, 70 mM of potassium phosphate (pH 6.0-8.0), Tris/HCl (pH 7.49.5) and borate/NaOH (9.0-10.0) buffers were used in the assay. Similarly, the
temperature dependence of AruH activity was evaluated by incubating the assay mixture
I for 4 min at 25-50°C.

2.3 RESULTS
2.3.1 Overproduction and purification of recombinant AruH.
The pBAD system was employed for over-expression of the recombinant AruH in E.
coli. However, initial attempts encountered two difficulties: low expression level and
formation of inclusion bodies. We have successfully overcome these problems by
integrating several features in the final recombinant strain. As described in Materials and
Methods, the aruH gene was cloned into the expression vector pBAD-HisA using the
strategy that allowed the N-terminus of AruH to fuse directly with a His6 tag rather than
through a linker region to minimize interference to the folding or bioactivity of
recombinant proteins. The resulting plasmid pYZNH3 was expressed at 22°C to reduce
the formation of inclusion bodies in the E. coli Rosetta (DE3), which has been proven to
be useful to overcome the codon bias problem. With these modifications, the His-tagged
AruH was expressed well and became soluble. After two steps of column
chromatography (affinity and anion exchange), the recombinant AruH protein was
purified to homogeneity as evidenced by SDS-PAGE (Fig. 2.1).
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2.3.2 Molecular mass and absorption spectrum.
As shown in Fig. 2.1, a value of 43 kDa for the molecular mass of the AruH was
determined from a plot of electrophoretic mobility against the logarithm of the molecular
masses of known polypeptides. The results of gel filtration column chromatography
revealed an apparent molecular mass of 79.3 kDa for native enzymes (Fig. 2.2),
indicating that the His-tagged AruH is a homo-dimer.
The purified AruH proteins had a distinct yellow color, suggesting the presence of a
bound chromophore. As demonstrated below, AruH possessed a PLP-dependent
transamination activity. UV/VIS spectroscopic analysis of AruH revealed an absorption
peak centered at 425 nm (Fig. 2.9), consistent with the presence of PLP.

2.3.3 Assay of a PLP-dependent arginine:pyruvate transaminase activity of AruH.
As described in Chapter One (Yang and Lu, 2007b), several lines of genetic and
biochemical evidences led us to propose that AruH possesses an arginine:pyruvate
transaminase activity. In this reaction, L-arginine and pyruvate served as the amino donor
and acceptor, respectively, to make 2-ketoarginine and L-alanine. The amount of Lalanine thus synthesized was measured by the generation of NADH in a coupled reaction
by a NAD-dependent L-alanine dehydrogenase as described in Materials and Methods.
With this assay, it was found that only negligible L-alanine production could be detected
in the absence of PLP, indicating that AruH is a PLP-dependent enzyme.
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HPLC and MS analyses were employed to demonstrate the generation of 2ketoarginine and L-alanine in the proposed reaction by AruH. Two transamination
reaction mixtures were prepared, one with active AruH and another with heat-inactivated
AruH as negative control. As shown in Fig. 2.3, the presence of 2-ketoarginine in the
reaction was tentatively identified by HPLC: a peak with the same retention time (5.9
min) as 2-ketoarginine standard only appeared in the reaction mixture of active AruH but
not in the negative control. However, the presence of L-alanine was difficult to
demonstrate by HPLC because of its relatively low molar extinction coefficient (79
versus 1350 M-1cm-1of L-arginine) at 205 nm and its close retention time (3.36 min) to Larginine (3.42 min) under this elution condition.
The same reaction mixtures were also analyzed by MS to detect the presence of Lalanine and 2-ketoarginine. In the mass spectrum of the reaction mixture with active
AruH (Fig. 2.4B), two molecular ion peaks were observed with m/z(-) value of 88.1 and
172.1, which are identical to those of authentic L-alanine and 2-ketoarginine,
respectively. As expected, no L-alanine and 2-ketoarginine were detected in the negative
control sample which contained heat-inactivated AruH (Fig. 2.4A). Taken together, these
results indicated that AruH is a PLP-dependent arginine:pyruvate transaminase that yields
2-ketoarginine and L-alanine.
We also investigated the reverse reaction catalyzed by AruH using 2-ketoarginine and
L-alanine as substrates. No significant production of L-arginine or pyruvate, however,
was observed from HPLC analyses as described in Materials and Methods. This could be
due to the fact that our assay conditions were not optimal for the reverse reaction.
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2.3.4 Optimal pH and temperature.
As shown in Fig. 2.5, the optimal pH for AruH enzyme activity was pH 9.0.
Borate/NaOH buffer in this case showed a strong inhibition effect on the transamination
activity of AruH. The optimal temperature for AruH enzyme activity was 42°C; the
enzyme was prone to a sharp thermal inactivation above this temperature (Fig. 2.6).

2.3.5 Steady state kinetics with L-arginine and pyruvate as substrates.
Taking L-arginine and pyruvate as the substrates, Lineweaver-Burk plots of the data
revealed a series of parallel lines characteristic of ping-pong kinetics mechanism (Fig.
2.7A and 2.7B). The calculated Vmax and kcat were 54.6 ± 2.5 µmol/min/mg and 38.6 ±
1.8 s-1. The apparent Km and catalytic efficiency (kcat/Km) for pyruvate were 1.6 ± 0.1
mM and 24.1 mM-1 s-1, respectively. The apparent Km and catalytic efficiency (kcat/Km)
for L-arginine were 13.9 ± 0.8 mM and 2.8 mM-1 s-1, respectively.

2.3.6 Substrate specificity.
AruH was tested with ornithine, D-arginine and nineteen natural amino acids (except
L-alanine) as amino donors in the presence of pyruvate as the amino acceptor. While Larginine was found to be the best substrate among these amino acids, AruH also exhibited
the catalytic activity toward L-lysine, L-methionine, L-leucine, ornithine and L-glutamine
with less efficiency (TABLE 2.1). In the mass spectrum of the reaction mixture with Llysine as substrate (Fig. 2.8), a molecular ion peaks was observed with m/z(-) value of
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126.1, which suggests the production of ∆1-piperideine-2-carboxylate. As expected, no
such signal peak was detected in the negative control sample which contained inactivated
AruH (Fig. 2.8). These results indicated that AruH is a transaminase with broad substrate
specificity.
We also tested whether α-ketoglutarate could substitute pyruvate as an alternative
amino acceptor in the AruH-catalyzed deamination of L-arginine and L-lysine. However,
no synthesis of glutamate could be detected in a coupled reaction with NAD+-dependent
glutamate dehydrogenase.

2.4 DISCUSSION
To our knowledge, this is the first report of an arginine transaminase being
characterized at the molecular level. We provided solid evidences herein to support that
AruH is a PLP-dependent arginine:pyruvate transaminase. In conjunction with genetic
studies in Chapter One (Yang and Lu, 2007b), we established the physiological function
of AruH as the first catalytic enzyme of the arginine transaminase pathway for L-arginine
utilization in P. aeruginosa. The high Km value of AruH for L-arginine (13.9 ± 0.8 mM)
might provide an explanation why the arginine transaminase pathway in P. aeruginosa is
not the preferred pathway and only active when the major pathway, the arginine
succinyltransferase (AST) pathway is blocked. Like many other arginine catabolic
enzymes, AruH also displayed an optimal pH at 9.0 which might be due to intracellular
alkaline environment through arginine utilization.
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In pseudomonas genome annotation (www.pseudomonas.com), AruH was initially
described as an aspartate transaminase (AspTA) because of its significant sequence
similarities to other bacterial AspTAs, which belong to subgroup I of the transaminase
family (Mehta et al., 1993). The AspTAs in subgroup I may be further subdivided into
two subgroups, Ia and Ib, according to their mutual homologies (Okamoto et al., 1996).
AruH showed significant sequence identities (27%-39%) and similarities (47-57%) with
AspTAs of subgroup Ib but not with those of subgroup Ia. For AspTAs, an R-292 residue
of subgroup Ia (Fotheringham et al., 1986) or a K-109 residue of subgroup Ib (Nobe et
al., 1998) is highly conserved to interact with the distal carboxyl group of aspartate. None
of these two residues is conserved in the corresponding sites of AruH, consistent with our
conclusion that AruH is not an aspartate transaminase. Since L-arginine is the best
substrate for AruH, one would expect the presence of specific interactions between the
guanidino group of L-arginine and the side chains of amino acid residues in the catalytic
pocket of this enzyme. Although the comparison of predicted 3D structure of AruH and
the known structure aspartate transaminase (Thermus Thermophilus) could not offer the
hints (Fig. 2.11), future determination of the molecular structure of AruH would expect to
answer these questions of substrate recognition mechanism. It was noteworthy, however,
that those amino acid invariants well conserved in AspTAs of subgroup I (Mehta et al.,
1989), including Y70, P138, N194, P195, G197, D222, Y225, K258, R266, G268, and
A386 (the residues are numbered according to pig cytosolic AspTA), could still be found
in the sequence of AruH (Fig. 2.10). Analogous to the roles played by these residues in
members of the transaminase family subgroup I, we propose that K-237 of AruH is the
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active lysyl residue that binds to the coenzyme PLP, D-204 of AruH may form a
hydrogen bond to N(1) of the coenzyme, and R365 of AruH may function in binding the
α-carboxyl group of substrates.
The conversion of L-arginine into 2-ketoarginine via transamination has been
previously reported in Arthrobacter simplex (Tachiki et al., 1980). Different from the
arginine:2-ketoglutarate transaminase of A. simplex, AruH prefers to use pyruvate as the
amino acceptor, but not 2-ketoglutarate. Those two enzymes are, however, both PLPdependent and showed an arginine-inducible expression profile. Compared to the enzyme
of A. simplex which could utilize L-arginine (100%) but also L-citrulline (16%) and Lalanine (10%), AruH displayed broader substrate specificity and could utilize L-lysine
(51%), L-methionine (44%), L-leucine (24%), and L-ornithine (17%) besides L-arginine
(100%) as the amino donor. It would be of interest to exploit whether AruH plays a role
in utilization of these amino acids, and reciprocally whether these amino acids exert any
effect on induction of aruH and other genes in the same locus. For instance, the
production of ∆1-piperideine-2-carboxylate via the transamination between L-lysine and
pyruvate as demonstrated in this report might provide an alternative pathway for lysine
catabolism (Revelles et al., 2005).
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TABLE 2.1. Substrate specificity of AruH.
Amino donor
L-arginine
L-lysine
L-methionine
L-leucine
L-ornithine
L-glutamine
Other amino acidsb
a

Relative activity (%)a
100
51
44
24
16.5
2.3
NRc

Pyruvate (20 mM) and amino donors (20 mM) as indicated were used as substrates, and
the initial reaction rate was measured by analyzing L-alanine production in the coupled
reaction as described in Materials and Methods. The activity of AruH with L-arginine as
substrate was defined as 100%. All experiments were performed in duplicate.
b
Other amino acids tested as the amino donor included all other L-amino acids (except
L-alanine) and D-arginine.
c
NR, not reactive or the activities were below the detection limit of the employed
method.
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FIG. 2.1. Purification of the recombinant AruH. Proteins were separated on a 10% SDSpolyacrylamide gel. Lane M, protein markers with sizes shown on the right; lane 1, cellfree extract before purification; lane 2, the AruH fraction from the affinity column; lane
3, the AruH fraction from the anion exchange column.
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FIG. 2.2. Dimeric state of recombinant AruH. Known protein standards (solid squares)
were used to calculate a standard curve. The recombinant AruH proteins were eluted with
an apparent molecular mass of 79.3 kDa. The r2 value for the linear regression of the
standard curve was 0.974.
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FIG. 2.3. HPLC analysis of the AruH reaction products. Chromatograms of components
of the reaction mixture either with heat-inactivated AruH (dashed line) or active AruH
(solid line) were recorded at 205 nm as described in Materials and Methods. Signal peaks
were individually identified, according to the same retention times as of authentic
reference compounds. In this system, the retention times for L-arginine (L-arg), pyruvate
(Pyr), 2-ketoarginine (2-KA), L-alanine and PLP were 3.42 min, 4.2 min, 5.9 min, 3.36
min and 10.8 min, respectively.
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FIG. 2.4. ESIMS analysis of the AruH reaction products using L-arginine as substrate. Panels A and B represent analyses of
the reaction mixture with the heat-inactivated and the active AruH, respectively. The signals with an m/z of 87.0, 88.1, 172.1,
and 173.2 were in accordance with the negative ion of pyruvate (Pyr), L-alanine (L-ala), 2-ketoarginine (2-KA), and Larginine (L-arg).
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FIG. 2.5. The effect of pH on AruH activity. The arginine:pyruvate transaminase
activities of AruH at pH 6.0-10.0 and 37°C were determined as described in Materials
and Methods. The reaction mixture contained 20 mM of L-arginine and pyruvate in 70
mM of the following buffers: potassium phosphate pH 6.0-8.0 (filled circles); Tris-HCl
pH 7.5-9.5 (open circles); borate/NaOH pH 9.0-10.0 (filled triangles). For comparison,
the specific activity of AruH at pH 9.0 in Tris-HCl was defined as 100%. All experiments
were performed in triplicate, and the averages of specific activities were used for
comparison.

69

FIG. 2.6. The effect of temperature on AruH activity. Figure shows the arginine:pyruvate
transaminase activity of AruH at temperature from 25-50 °C with 20 mM L-arginine and
20mM pyruvate. For comparison, the specific activity of AruH at 42 °C was defined as
100%. Each assay was initiated by the addition of 10 µg of recombinant AruH. All
experiments were performed in triplicate, and the averages of specific activities were
used for comparison.
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FIG. 2.7. Lineweaver-Burk plot of AruH activities with L-arginine and pyruvate as
substrates. Kinetic studies were performed as described in Materials and Methods. Panel
A, the concentration of L-arginine (L-arg, the amino donor) was varied at the fixed
concentrations of pyruvate (Pyr, the amino acceptor) as indicated. Panel B, the
concentration of pyruvate was varied at the fixed L-arg concentrations as indicated. All
experiments were performed in triplicate, and error bar denotes the standard deviation.
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FIG. 2.8. ESIMS analysis of the AruH reaction products using L-lysine as substrate. Panels A and B represent the ESIMS
analysis of the reaction mixture with heat-inactivated and active AruH, respectively. The signals with an m/z of 87.0, 88.1,
126.1 and 145.1 were in accordance with the negative ion of pyruvate (Pyr), L-alanine (L-ala), ∆1-piperideine-2-carboxylate,
and L-lysine (L-lys).
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FIG. 2.9. UV/VIS spectroscopic analysis of AruH and authentic PLP. Absorption spectra
of the purified protein (8 mg/ml) and authentic PLP (1 mM) dissolved in 20 mM
Tris/HCl (pH7.4) were recorded at 25°C.
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FIG. 2.10. Comparison of the sequences of aminotransferase from different species. The residues are numbered according to
the sequence of pig cytosolic AspAT (cPig). AruH, arginine:pyruvate transaminase from P. aeruginosa; PFL2715, AruH
homolog from P. fluorescence; PP3721, AruH homolog from P. putida; B. SP. YM-2, thermostable AspAT from Bacillus sp.
strain YM-2; ThermusHB8, AspAT from Thermus thermophilus strain HB8; Sulfolobus, AspAT from Sulfolobus solfataricus;
PA3139, AspAT from P. aeruginosa. Residues that are invariant in all the compared sequences are highlighted.
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FIG. 2.11. Structure of comparison of Thermus Thermophilus aspartate transaminase (left) and Pseudomonas aeruginosa AruH
(right) with front view. The predicted structure of Pseudomonas aeruginosa AruH was proposed using Adanced Molecular
Modeling Program (AMMP) and the structure of Thermus Thermophilus aspartate transaminase as the template.
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Chapter Three
Identification of Candidate Genes for D-arginine Catabolism in P. aeruginosa PAO1
Using DNA Microarray.

3.1. INTRODUCTION
We provided the solid evidences (Yang and Lu, 2007a; Yang and Lu, 2007b) to
support that in P. aeruginosa PAO1 L-arginine is converted into 2-ketoarginine via
transamination instead of oxidative deamination by D-arginine dehydrogenase coupled
with arginine racemase as originally proposed when the major pathway for arginine
utilization, the arginine succinyltransferase (AST) pathway, is blocked. Our results also
showed that the block of the AST and ATA pathways abolished the capacity of P.
aeruginosa to utilize L-arginine as the sole source of carbon and nitrogen (Yang and Lu,
2007b), thus indicating that no other alternative routes for L-arginine utilization exist in
this microorganism. Although, our studies have ruled out the significance of D-arginineinducible D-arginine dehydrogenase in L-arginine utilization; this yet-to-be-identified
enzyme could still provide routes for D-arginine utilization. Since P. aeruginosa could
grow on D-arginine as the only carbon and nitrogen source (Itoh, 2004; Jann et al., 1988),
the physiological functions of D-arginine dehydrogenase in arginine metabolism warrant
further investigation.
Traditional methods to identify genes of metabolic pathway usually are time
consuming. With the completion of the P. aeruginosa Genome Project (Stover et al.,
2000) and the development of innovative DNA microarray technology, it becomes

76
feasible to identify the unknown genes of metabolic pathway in an efficient and
systematic way. As demonstrated by our previous work (Lu et al., 2004; Yang and Lu,
2007b), this technology is especially useful for the study of cell metabolism. Thus, to
identify the candidates for D-arginine dehydrogenase in P. aeruginosa, we still decided to
employ DNA microarray technology to analyze the transcriptional profiles of this
organism in response to D-arginine.

3.2. MATERIALS AND METHODS
3.2.1 D-arginine dehydrogenase assay.
For the measurements of enzyme activities, cell cultures in the logarithmic phase were
collected by centrifugation, and the cell pellets were washed twice using 50 mM
potassium phosphate buffer, pH 7.0, and resuspended in the same buffer. Cells were
broken with a French pressure cell at 8,000 lb/in2, and soluble cell extracts were prepared
after centrifugation at 25,000 x g for 20 min. Protein concentration was determined by the
method of Bradford with bovine serum albumin as the standard.
D-arginine dehydrogenase was assayed with the addition of artificial electron
acceptors, phenazine methosulphate (PMS) and iodonitrotetrazolium chloride (INT), as
described by Jann and Haas (Jann et al., 1988). Briefly, the assay mixture (1.0 ml; final
volume) contained 0.1 M Tris/HCl (pH 8.7), 20 mM D-arginine, 10mM potassium
cyanide, 0.8 mM INT, 0.8 mM PMS, and crude extract (0.1-1.0 mg protein). The assay
mixture was pre-incubated for 10 min at 37 °C prior to the addition of INT, PMS and
crude extract. The reaction was stopped by the addition of 0.1 ml 4 M HCl, and the
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increase of the absorbance at 500 nm was measured. Blanks did not contain D-arginine or
crude extract. The molar extinction coefficient (11500 M-1 cm-1) of reduced INT was
used for calculation. One unit of D-arginine dehydrogenase activity is defined as the
amount of the enzyme that led to the reduction of 1 nmol of INT per minute under the
standard assay conditions.

3.2.2 DNA microarray.
Our GeneChip® (Affymetrix) experiments were done as described in Materials and
Methods of Chapter One (Yang and Lu, 2007b). Total RNA samples were prepared from
wild-type strain PAO1 grown in glutamate minimal medium in the presence or absence
of D-arginine under aerobic conditions using Qiagen RNeasy Kit. cDNA synthesis,
fragmentation, labeling, and GeneChip hybridization were performed according to the
protocol provided by the manufacturer (Affymetrix) as described in Chapter One (Yang
and Lu, 2007b). The results of two independent experiments for D-arginine conditions
were merged, and the merged data were used for subsequent comparisons and assessed
with Microarray Suite 5.0 software (Affymetrix). Absolute expression signal values were
normalized for each chip by globally scaling to a target intensity of 500. These data were
imported into the GeneSpring 6.1 software (Silicon Genetics) for further analysis based
on distinct expression patterns under these three conditions. Transcripts with the absence
call (P > 0.04) or with a signal level below 400 were eliminated.
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3.2.3 Construction of lacZ fusions.
Plasmid pQF52 (Park et al., 1997a), a broad-host-range lacZ translational fusion
vector, was used in the construction of promoter fusions of PA3862 and PA3865. DNA
fragments containing the regulatory regions of interest were amplified by PCR from the
genomic DNA of PAO1 with the following synthetic oligonucleotides designed to
generate HindIII restriction sites on the forward primers: for PA3862, 5’TACAAGCTTCTGTACAACCTGGTGGCGCAG-3’ and 5’-GGCGCTCATGCGATCT
CCGGAATGGATGTA-3’; and for PA3865, 5’-AGCAAGCTTCCCCCATTACAGACG
CGCCTC-3’ and 5’-GGTGTTCAGCGACTTGATCATGGACGACTC-3’. The PCR
products were purified from a 1% (wt/vol) agarose gel, digested by restriction
endonuclease HindIII, and ligated to the HindIII and SmaI sites of the translational fusion
vector pQF52. The resulting plasmids contain the entire upstream intergenic sequences of
the corresponding genes and the 5' ends of their coding sequences fused in-frame to the
eighth codon of the lacZ gene in the vector.

3.2.4 Construction of mutant strain.
Deletion mutant of PA3862-to-PA3862 was constructed as described below. DNA
fragments covering two flank regions of those genes were generated by PCR from the
genomic DNA of PAO1 with the following synthetic oligonucleotides designed to
generate restriction sites at the 5’ or 3’ ends of the PCR products: for PA3862 side flank
region, 5’-TTTGGATCCGGCGATCGTCGAGATCGAGCC-3’ (BamHI) and 5’-GTTG
AATTCTGGACTTTAAGGTATTGCCGG-3’ (EcoRI); for PA3865 side flank region,

79
5’-GAGGAATTCGGGTCCTTGAACTCCGGCCCG-3’ (EcoRI) and 5’-GGGAAGCTT
CGACTACGACATCGGCAACGC-3’ (HindIII). The PCR products were purified and
subcloned into the corresponding site of the conjugation vector pRTP1 (Stibitz et al.,
1986), followed by insertion of a gentamicin resistance cassette (Gm) into the EcoRI site.
For gene replacement, the resulting transposon insertion plasmids were first introduced
into E. coli SM10 and then mobilized into the spontaneous streptomycin-resistant P.
aeruginosa strain PAO1-Sm by biparental plate mating (Gamper et al., 1991). After
incubation at 37°C overnight, transconjugants were selected on LB plates supplemented
with gentamicin and streptomycin. Genotypes of all these constructed mutants were
verified by PCR.

3.3 RESULTS AND DISCUSSION
3.3.1 Assay of D-arginine dehydrogenase.
As shown in Table 3.2, D-arginine dehydrogenase activity was induced specifically
by D-arginine, but not by L-arginine. However, L-arginine did exert a significant
induction effect on D-arginine dehydrogenase activity in the aruF mutant in which the
major route of arginine utilization, the AST pathway, was blocked. Since aruF encodes
an arginine succinyltransferase catalyzing the first step of the AST pathway, it is possible
that the intracellular concentration of L-arginine in the aruF mutant was higher than that
in the wild type strain, and this may induce the arginine racemase activity and
subsequently the D-arginine dehydrogenase activity.
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P. aeruginosa could grow on D-arginine as the only carbon and nitrogen source (Itoh,
2004; Jann et al., 1988), although more slowly (doubling time 2 h) than on L-arginine
(doubling time 1.3 h, Table 1.5). We also have observed that D-arginine utilization was
partially retarded in the aruF mutant devoid of the AST pathway (doubling time 4 h),
suggesting the AST pathway is also the major route for D-arginine utilization. Because
D-arginine is a competitive inhibitor of the arginine succinyltransferase catalyzing the
first reaction of the AST pathway, D-arginine may have to be converted by a racemase
into L-arginine before it can be channeled into the AST pathway (Jann et al., 1988).
However, we could not exclude the possibility that D-arginine may serve as a substrate of
this enzyme. When the AST pathway was blocked, disruption of the ATA pathway in the
aruF mutant by either aruH or aruI did not result in further inhibition of growth on Darginine, thus indicating the presence of other alternative D-arginine catabolic pathways
in which D-arginine dehydrogenase may be involved.

3.3.2 Identification of genes induced by D-arginine in P. aeruginosa PAO1.
To identify and characterize the genes of D-arginine utilization in P. aeruginosa, we
employed DNA microarray to analyze the transcriptional profile of this organism in
response to D-arginine. We hypothesized that D-arginine catabolic genes should be
induced by D-arginine. Our transcriptome analyses identified 39 genes in 19 putative
transcriptional units (Table 3.1) falling into this group.
While many of these genes have not been characterized, the following observations
are interesting. First, the genes of the AST pathway, aruCFGDBE, were found to be also
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induced by D-arginine. This fits well to the hypothesis that D-arginine may be converted
by a racemase to L-arginine, which will be subsequently channeled into the AST
pathway. Second, PA3862-to-PA3864 and PA3865 genes were found to be highly
induced by D-arginine. Among these genes, PA3863 encode a putative oxidoreductase,
which could serve to catalyze the conversion of D-arginine into 2-ketoarginine as a Darginine dehydrogenase. These genes were also revealed in our previous transcriptome
analyses, but the expression of those genes were induced by L-arginine to much lesser
extent when compared to D-arginine. This might be explained by the distinct property of
D-arginine dehydrogenase, which is a specific D-arginine inducible enzyme. Third, the
gene cluster (PA1974-to-PA1990) was related to the biosynthesis of pyrroloquinoline
quinone (PQQ) (Goosen et al., 1992; Schnider et al., 1995; Velterop et al., 1995). This
molecule has similarity to vitamin B2 and vitamin B3, and is proven to be an important
cofactor in enzyme-catalyzed reduction–oxidation (redox) reactions. The co-induction of
this gene cluster with D-arginine dehydrogenase by D-arginine in P. aeruginosa PAO1
may suggest that PQQ functions as a cofactor for D-arginine dehydrogenase. Last, the
gbuA gene, which encodes 4-guanidinobutyrase of the ATA pathway, was also identified
in this list. The kauB gene encoding a bifunctional dehydrogenase for 4aminobutyraldehyde of the ADC pathway and a 4-guanidinobutyraldehyde (GUBAL) of
the ATA pathway, and the gabDT genes encoding parts of the ADC and ATA pathways,
however, were not identified as a D-arginine inducible gene. These unexpected results
strongly suggested that D-arginine might be utilized via a yet-to-be-identified pathway,
instead of via the ATA pathways as previous proposed.
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3.3.3 Validation of microarray data by promoter::lacZ fusions.
To validate microarray data, putative promoters for PA3862-to-PA3864 and PA3865
were selected for further analysis by lacZ fusions. These promoter::lacZ fusions were
constructed as described in Materials and Methods, and the effect of exogenous Darginine on expression of these promoters was analyzed by measurements of βgalactosidase activities in wild type strain PAO1 harboring the recombinant plasmids.
As shown in Table 3.3, while exogenous D-arginine exerted 14.2-fold and 7.1-fold of
induction on the PA3862 and PA3865 promoters respectively in wild type strain PAO1,
we did not observe the similar induction effect by exogenous L-arginine. Overall, these
results correlated well with microarray data in the induction pattern, and supported our
hypothesis that PA3863 may encode a D-arginine dehydrogenase for D-arginine
utilization by P. aeruginosa.
On the other hand, the results of transcriptome analysis did not support the proposed
pathway of D-arginine utilization as shown in Fig.3.1 (Jann et al., 1988). Specifically, the
kauB gene encoding GUBAL dehydrogenase and gabDT for the conversion of GABA
into succinate were not found in the list. These results depicted a wider network of
arginine metabolism than we previously recognized.

3.3.4 PA3862-to-PA3865 mutant.
To test our hypothesis that PA3863 may encode a D-arginine dehydrogenase, the
deletion mutant of PA3862-to-PA3865 was constructed as described in Materials and
Methods. As shown in Table 3.2, while a D-arginine inducible D-arginine dehydrogenase
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activity was detected in P. aeruginosa wild type strain PAO1 and its aruF mutant
PAO4558, this activity was abolished when a PA3862-to-PA3865 deletion was
introduced to the strain. This result supported the proposed biochemical function of
PA3863 and its potential role in D-arginine utilization.
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TABLE 3.1. Microarray analysis of genes induced by D-arginine P. Aeruginosa PAO1
Gene no.a
PA0565
PA0567
PA0895
PA0896
PA0897
PA0898
PA0899
PA0900
PA0901
PA1323
PA1421
PA1471
PA1818
PA1974
PA1975
PA1976
PA1977
PA1978
PA1979
PA1980
PA1981
PA1982
PA1983
PA1984
PA1985
PA1986
PA1987
PA1988
PA1989
PA1990
PA3441
PA3819
PA3862
PA3863
PA3864
PA3865
PA5182
PA5212
PA5526
a

Gene
name

aruC
aruF
aruG
aruD
aruB
aruE
gbuA

Protein description
Unknown
Unknown
N-Succinylglutamate 5-semialdehyde dehydrogenase
Arginine/Ornithine succinyltransferase AI subunit
Arginine/Ornithine succinyltransferase AII subunit
Succinylglutamate 5-semialdehyde dehydrogenase
Succinylarginine dihydrolase
Unknown
Succinylglutamate desuccinylase
Unknown
Guanidinobutyrase
Unknown

Ornithine/Arginine/Lysine decarboxylase

exaA
exaB
pqqA
pqqB
pqqC
pqqD
pqqE

Unknown
Unknown
Two-component sensor
Unknown
Transcriptional regulator
Two-component sensor
Two-component regulator
Unknown
Quinoprotein alcohol dehydrogenase
Cytochrome c550
Unknown
Pyrroloquinoline quinone biosynthesis protein A
Pyrroloquinoline quinone biosynthesis protein B
Pyrroloquinoline quinone biosynthesis protein C
Pyrroloquinoline quinone biosynthesis protein D
Pyrroloquinoline quinone biosynthesis protein E
Unknown
Molybdopterin-binding protein
Unknown
Unknown
FAD dependent oxidoreductase
Unknown
Amino acid binding protein
Unknown
Unknown
Unknown

Absolute signal valueb
PAO 1 (E) PAO1 (ER1) PAO1 (ER2)
245
6,686
3,127
53
619
628
849
5,749
5,134
529
3,409
4,733
377
3,900
3,459
284
3,086
2,524
466
4,299
3,631
2,880
8,775
7,109
691
2,683
2,986
140
1,021
1,398
67
397
1,488
338
3,341
2,770
739
3,797
2,469
28
2,448
375
47
3,262
1,279
39
1,406
1,278
97
768
243
198
5,690
1,244
3
415
247
11
354
270
41
9,246
7,629
54
13,309
6,795
14
14,476
6,799
1,911
13,810
7,646
116
3,997
2,122
188
6,113
3,806
174
5,229
3,079
240
6,313
3,680
159
2,543
1,697
64
1,308
1,164
149
747
821
599
4,819
4,308
215
10,699
7,718
81
3,933
2,561
158
2,495
1,893
205
4,229
5,451
933
5,043
5,788
544
4,674
4,801
135
898
1,385

Gene numbers are from the Pseudomonas Genome Project (www.pseudomonas.com).
Genes that were also induced by agmatine, putrescine and spermidine were marked with
asterisks. The expression profiles of argF and aruF at the end of this list represented
ArgR-dependent repression and activation, respectively.
b
Abbreviations: E, cells were grown in glutamate minimal medium P (MMP); ER, cells
were grown in glutamate MMP supplied with 20 mM L-arginine.
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TABLE 3.2. Measurements of D-arginine dehydrogenase activities in P. aeruginosa
PAO1 and its mutant strains.
Strains (Genotype)
PAO1 (wild type)
PAO4558 (aruF)
∆PA3862-to-PA3865
a

Sp acta (u / mg proteins)
Glu
Glu + L-arg Glu + D-arg
<0.1
2
836
<0.1
215
826
<0.1
<0.1
59

Cells were cultured to mid-log phase (OD600 = 0.5) in MMP-glutamate medium with or
without D-arginine and L-arginine. Cell extracts preparation and the enzyme assays were
described in Materials and Methods.
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TABLE 3.3. Verification of microarray data by promoter-lacZ fusions.
Gene no.
(name)a
PA3862
PA3865
a

Host strain
(genotype)
PAO1 (wild type)
PAO1 (wild type)

Sp actb (µmol/min/mg)
Glu
Glu + L-arg Glu + D-arg
26
34
372
350
91
2,467

Gene numbers and names are from the Pseudomonas Genome Project
(www.pseudomonas.com).
b
Specific activities are average of three measurements for each growth condition, with
standard errors of less than 5%. Glu, cells were grown in glutamate minimal medium P
(MMP); Glu+L-Arg, cells were grown in glutamate MMP supplied with 20 mM Larginine; Glu+D-Arg, cells were grown in glutamate MMP supplied with 20 mM Darginine.
c
Fold changes of gene expression are indicated by the ratio of cells grown in glutamate
MMP in the presence of arginine to cells grown in glutamate MMP in the absence of
arginine.
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FIG. 3.1. D-arginine catabolic pathways in P. aeruginosa PAO1. Only relevant
intermediates and genes are indicated. AST, arginine succinyltransferase pathway; ATA,
arginine transaminase pathway; TCA, tricarboxylic acid. Illustrated were four possible
routes for D-arginine utilization: 1) direct route through the AST pathway; 2) D-arginine
to L-arginine via arginine racemase, followed by the AST pathway; 3) the D-arginine
dehydrogenase pathway as originally proposed; and 4) D-arginine to 2-ketoarginine via
D-arginine dehydrogenase, followed by unknown steps. Other abbreviations are shown as
in Figure 1.1.
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Overall Summary
Pseudomonas aeruginosa is a Gram-negative bacterium that causes life-threatening
infections in immunocompromised persons and chronic infections in cystic fibrosis
patients. The potential pathogenicity of this opportunistic human pathogen is greatly
enhanced by its extraordinary nutritional versatility, which gives it an exceptional ability
to colonize ecological niches where nutrients are limited. Arginine catabolism is of
particular significance in this regard because P. aeruginosa can utilize L-arginine
efficiently as the sole source of carbon, nitrogen and energy through different pathways,
including the arginine deiminase (ADI) pathway, the arginine succinyltransferase (AST)
pathway, and the arginine transaminase (ATA) pathway recently reported by our research
group. Our results indicate that the AST and ATA pathways are the only two functional
routes for L-arginine utilization under aerobic conditions. The arginine decarboxylase
(ADC) pathway may not contribute to arginine utilization due to the lack of an arginineinducible ADC activity, but rather serve to supply putrescine when arginine is abundant.
Nevertheless, exogenous agmatine or putrescine indeed can induce all the enzymes
following its entry point of the ADC pathway, and thus be utilized as the sole source of
carbon and nitrogen through this pathway.
Functional genomics approach using DNA microarray is an appropriate and efficient
way to identify genes of metabolic pathways in organisms with completed genome
projects. In this case, P. aeruginosa genome contains 5,570 open reading frames, and
traditional genetic approach of random mutagenesis was proven to be difficult for the
identification of the remaining unknown genes for arginine catabolism. We chose DNA
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microarray to analyze the transcriptional profiles of this organism in response to Larginine. We used data mining method to identify the ArgR-independent arginineinducible genes, thus successfully dramatically decreasing the number of candidate genes
in the first shot. With the help of bioinformatics tools including but not limited to
sequence homology analysis and conserved motif search, we chose only seven genes
encoding putative enzymes for the proposed pathway for the further investigation. Our
study finally led to the revision of the arginine transaminase (ATA) pathway, the first
report of an arginine:pyruvate transaminase, and the identification of genes which encode
2-ketoarginine decarboxylase and arginine responsive two-component regulator proteins.
Based on our experimental results, we also proposed a model (Fig. 4.1) to explain
why the genes of the ATA pathway showed the expression pattern as argR independent
and arginine inducible genes. In the presence of a functional ArgR protein, P. aeruginosa
chooses the AST pathway as a preferred a route to utilize L-arginine, and therefore the
genes of this pathway is induced. Since the ATA pathway is not active at this time, the
genes of the ATA pathway show basal level of expression. When the activator
responsible for the arginine induction effect of the AST pathway, the ArgR protein is
inactivated, the genes of the AST pathway will not be induced by L-arginine any more,
thus leading to the block of this major arginine catabolic pathway. Under this
circumstance, P. aeruginosa will be forced to choose an auxiliary route, the ATA
pathway, to utilize L-arginine. While all the genes of the AST pathway belong to a single
operon, the aru operon, and co-regulated by the ArgR protein, the genes of the ATA
pathway is not clustered together and may be divided into different regulatory units
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independent of the ArgR protein. Since those genes are still the arginine catabolic genes,
they displayed a gene expression pattern as argR independent and arginine inducible
genes.
Moreover, although we haven’t completed that project yet, DNA microarray also
gave us a very promising data which may help to illustrate the unknown catabolic
network for D-arginine utilization in P. aeruginosa PAO1. PA3863 encoding a Darginine dehydrogenase and the remaining steps after 2-ketoarginine yet to be identified
warrant future investigations.
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FIG. 4.1. Proposed model for L-arginine utilization in P. aeruginosa PAO1.
Abbreviations are shown as in Figure 1.1.
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